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ABSTRACT 
Winger, Joseph G. Ph.D., Purdue University, August 2017. Associations Between Coping 
Skills Practice and Symptom Change in a Psychosocial Symptom Management 
Intervention for Lung Cancer Patients and Their Family Caregivers. Major Professor: 
Catherine E. Mosher. 
 
 
Little research has explored the degree to which specific intervention components predict 
improved health outcomes for cancer patients and their family caregivers.  The present 
study examined relations of intervention components (i.e., coping skills) to symptoms in 
a telephone symptom management (TSM) intervention delivered concurrently to 
symptomatic lung cancer patients and their family caregivers.  Guided by Social 
Cognitive Theory (SCT) and cognitive behavioral therapy (CBT) frameworks, patient-
caregiver dyads were taught coping skills including: a mindfulness exercise (i.e., noticing 
sounds and thoughts), pursed lips breathing, guided imagery, cognitive restructuring, and 
assertive communication.  Symptom measures were administered at baseline and 2 and 6 
weeks post-intervention.  The measures assessed patient and caregiver depressive and 
anxiety symptoms as well as patient pain severity, distress related to breathlessness, and 
fatigue interference.  Data were examined from patient-caregiver dyads enrolled in TSM 
(N = 51 dyads).  Patients and caregivers were predominantly female (55% and 73%, 
respectively) and Caucasian (87%).  The average patient was 63 years of age (SD = 8) 
and the average caregiver was 56 years of age (SD = 14).  Seven autoregressive panel
x 
 
models tested relations of coping skills to symptoms.  All models had at least adequate fit 
to the data (χ2 ps > 0.05, RMSEA values < 0.06).  For patients, more assertive 
communication practice during the intervention was related to less pain severity, fatigue 
interference, and depressive and anxiety symptoms at 6 weeks post-intervention.  
Additionally, more guided imagery practice during the intervention was related to less 
fatigue interference and anxiety at 6 weeks post-intervention.  In contrast, more cognitive 
restructuring practice during the intervention was related to more distress related to 
breathlessness and depressive and anxiety symptoms at 6 weeks post-intervention.  
Similarly, more practice of a mindfulness exercise during the intervention was related to 
more fatigue interference and anxiety at 6 weeks post-intervention.  For caregivers, more 
guided imagery practice was related to more anxiety at 2 weeks post-intervention.  All 
other pathways from coping skills to symptoms at 2 and 6 weeks post-intervention were 
non-significant for both patients and caregivers.  Findings suggest intervention 
effectiveness may have been reduced by competing effects of certain coping skills.  For 
lung cancer patients, future studies should consider focusing on assertive communication 
and guided imagery, as these two coping skills were most consistently associated with 
reduced symptoms.  However, more studies are needed to better understand these 
findings and particular caution should be used when applying CBT-based interventions 
that have not been validated in lung cancer populations.  
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BACKGROUND 
Introduction 
For many individuals, cancer can be conceptualized as a “dyadic disease” that 
profoundly impacts both the patient and his or her caregiver (Badr & Krebs, 2013; 
Hagedoorn, Sanderman, Bolks, Tuinstra, & Coyne, 2008; Manne & Badr, 2008).  Thus, 
over the past two decades, numerous psychosocial interventions have focused on 
improving outcomes for cancer patients and their caregivers (Badr & Krebs, 2013; Baik 
& Adams, 2011; Martire, Schulz, Helgeson, Small, & Saghafi, 2010; McLean & Jones, 
2007; Regan et al., 2012).  Dyadic interventions (i.e., psychosocial interventions with 
patients and caregivers jointly participating) have shown small to moderate effects on a 
range of patient and caregiver outcomes (Badr & Krebs, 2013; Regan et al., 2012).  Little 
is known, however, about the effective components of these interventions.   
Identifying effective intervention components is an essential step in developing 
cost-effective and efficacious interventions (Czaja, Schulz, Lee, & Belle, 2003; Kazdin, 
2007).  One method for testing intervention components is to explore associations 
between intervention components and outcomes (Andersen, Shelby, & Golden-Kreutz, 
2007; Chan, Richardson, & Richardson, 2012; Kazantzis, Whittington, & Dattilio, 2010). 
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Currently, component-outcome associations remain understudied in both cancer 
(Andersen et al., 2007; Chan et al., 2012; Cohen & Fried, 2007; Matthews, Schmiege, 
Cook, Berger, & Aloia, 2012; Tremblay, Savard, & Ivers, 2009) and non-cancer 
populations (e.g., patients with chronic pain) (Curran, Williams, & Potts, 2009; Heapy et 
al., 2005; Jensen, Turner, & Romano, 2001); moreover, no studies have examined these 
associations in dyadic interventions for cancer patients and their caregivers.  The current 
study addresses this gap in the literature by examining associations between intervention 
components and symptom change in a telephone-delivered symptom management 
intervention for lung cancer patients and their family caregivers. 
In the following sections I discuss the symptom burden of lung cancer and present 
the current empirical support for dyadic interventions for patient and caregiver 
symptoms.  Following, I describe previous studies that have examined component-
outcome associations in psychosocial interventions for cancer patients.  Next, I provide 
theoretical explanations for the associations between intervention components and 
symptom change.  Lastly, I present my aims and hypotheses. 
 
Symptom Burden of Lung Cancer 
 In 2016, it is estimated that 224,390 new cases of lung cancer will be diagnosed in 
the United States (American Cancer Society, 2016).  Accounting for around 25% of all 
cancer deaths, lung cancer causes more deaths per year than breast, prostate, and colon 
cancers combined (American Cancer Society, 2016).  Approximately 85% of lung cancer 
patients are diagnosed at advanced stages (i.e., stage III or IV non-small cell lung cancer 
and extensive small cell lung cancer) (American Cancer Society, 2016), which 
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contributes to high rates of debilitating symptoms (Dudgeon, Kristjanson, Sloan, 
Lertzman, & Clement, 2001; Hopwood & Stephens, 1995; Hopwood & Stephens, 2000).  
 The symptom burden of lung cancer and its treatment is well documented 
(Dudgeon et al., 2001; Hopwood & Stephens, 1995; Kurtz, Kurtz, Stommel, Given, & 
Given, 2002; Rolke, Bakke, & Gallefoss, 2008; Zabora, Brintzenhofeszoc, Curbow, 
Hooker, & Piantadosi, 2001).  Lung cancer patients report high rates of frequent and 
severe symptoms such as depressive and anxiety symptoms, pain, breathlessness, and 
fatigue (Dudgeon et al., 2001; Mercadante & Vitrano, 2010; Potter & Higginson, 2004; 
Tanaka, Akechi, Okuyama, Nishiwaki, & Uchitomi, 2002b; Zabora et al., 2001).  In the 
following sections each of these symptoms are discussed separately; however, it is 
important to note that most lung cancer patients experience multiple symptoms that often 
interact to increase functional impairment (D. J. Brown, McMillan, & Milroy, 2005; 
Hopwood & Stephens, 1995; Rolke et al., 2008; Tanaka et al., 2002b).  
Lung cancer patients report greater depressive and anxiety symptoms compared to 
patients with other common cancers (Linden, Vodermaier, MacKenzie, & Greig, 2012; 
Zabora et al., 2001).  Based on validated self-report measures, rates of clinically 
significant psychological distress range from 18% to 55% for depressive symptoms and 
24% to 56% for anxiety symptoms (Linden et al., 2012; Rolke et al., 2008; Zabora et al., 
2001).  Longitudinal studies suggest that depressive and anxiety symptoms typically 
persist throughout the disease trajectory, with levels of distress at diagnosis strongly 
predicting future distress (Akechi et al., 2006; Cooley, Short, & Moriarty, 2003; 
Hopwood & Stephens, 2000).  Increased depressive and anxiety symptoms have been 
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associated with decreased social functioning and reduced health-related quality of life 
(Cooley et al., 2003; Hopwood & Stephens, 2000; Rolke et al., 2008).   
One of the most consistent predictors of increased depressive and anxiety 
symptoms in lung cancer patients is female gender (Hagedoorn et al., 2008; Hopwood & 
Stephens, 1995; Hopwood & Stephens, 2000).  Some argue that this gender difference 
reflects the higher prevalence of depressive and anxiety symptoms for women in the 
general population (Davis, Matthews, & Twamley, 1999; Mirowsky & Ross, 1995; 
Nolen-Hoeksema, 2001).  Additionally, this gender difference may reflect the dynamic 
and reciprocal nature of physical and psychological symptoms (Hagedoorn et al., 2008; 
Hirsh, Waxenberg, Atchison, Gremillion, & Robinson, 2006; Riley, Robinson, Wade, 
Myers, & Price, 2001).  For example, women often experience a heightened response to 
physical symptoms (e.g., fatigue and pain) relative to men, which in turn may increase 
their psychological distress (Hirsh et al., 2006; Riley et al., 2001).  
Increased depressive and anxiety symptoms in lung cancer patients have also been 
consistently associated with worse performance status (Hopwood & Stephens, 1995; 
Hopwood & Stephens, 2000).  Performance status refers to a global assessment of 
patients’ functional ability and self-care and is the primary variable that oncologists use 
to make lung cancer treatment decisions and monitor treatment tolerability (Buccheri, 
Ferrigno, & Tamburini, 1996; Oken et al., 1982; Pfister et al., 2004; J. W. Yates, 
Chalmer, & McKegney, 1980).  The gold standard for quantifying patient performance 
status is the Eastern Cooperative Oncology Group (ECOG) score (Oken et al., 1982).  
Higher ECOG scores equate to worse functioning, with scores ranging from 0 (able to 
function at a pre-disease level) to 5 (death) (Oken et al., 1982).  Therefore, in general, 
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patients with frequent and severe physical symptoms have worse performance statuses 
(Buccheri et al., 1996; Oken et al., 1982).  Regarding the strong, negative association 
between performance status and psychological symptoms, patients with diminished 
ability to care for themselves may feel more depressed and anxious, which in turn may 
decrease their motivation for self-care and exacerbate their physical symptoms (Hopwood 
& Stephens, 2000).    
Lung cancer patients report high rates of pain (Mercadante & Vitrano, 2010; 
Potter & Higginson, 2004; van den Beuken-van Everdingen et al., 2007; Wildgaard et al., 
2011).  A systematic review of 32 studies with lung cancer patients noted that the 
weighted mean prevalence of pain was 47% (range = 6% to 100%) (Potter & Higginson, 
2004).  Across studies, pain was attributed to the cancer tumor and/or metastases 
(weighted mean = 73%, range 44% to 87%) as well as cancer treatment (weighted mean 
= 11%, range 5% to 17%) (Potter & Higginson, 2004).  Increased pain in cancer patients 
has been associated with decreased engagement in social activities, lower levels of social 
support, increased psychological distress, and reduced health-related quality of life 
(Herndon et al., 1999; Mercadante & Vitrano, 2010; Potter & Higginson, 2004; Zaza & 
Baine, 2002).  Additionally, a longitudinal study with lung cancer patients found that 
increased pain predicted mortality above and beyond performance status, tumor 
histology, weight loss, breathlessness, and fatigue (Herndon et al., 1999). 
One of the most frequent and distressing symptoms experienced by lung cancer 
patients is breathlessness (Dudgeon et al., 2001; Hopwood & Stephens, 1995; Quast & 
Williams, 2009; Tanaka, Akechi, Okuyama, Nishiwaki, & Uchitomi, 2002a).  A 
systematic review of ten studies with lung cancer patients found the average prevalence 
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of breathlessness to be 71% (range 50% to 87%) (Quast & Williams, 2009).  Moreover, 
the authors noted that the average patient reported a moderate level of distress (mean 
distress level = 2.1 out 5) related to his or her breathlessness (Quast & Williams, 2009).  
Qualitative studies have highlighted the particularly frightening nature of breathlessness, 
with lung cancer patients describing the symptom as “suffocating” or a “feeling of 
impending death” (Lai, Chan, & Lopez, 2007; O'Driscoll, Corner, & Bailey, 1999).  
Increased breathlessness in lung cancer patients has been consistently related to increased 
psychological distress and pain as well as worse performance status (Bruera, Schmitz, 
Pither, Neumann, & Hanson, 2000; Dudgeon et al., 2001; Hopwood & Stephens, 1995; 
Tanaka et al., 2002a).  
The majority of cancer patients experience at least some fatigue, regardless of 
cancer type or time since diagnosis (Hofman, Ryan, Figueroa-Moseley, Jean-Pierre, & 
Morrow, 2007; Oh & Seo, 2011).  In contrast to the other symptoms discussed, there has 
been debate in the cancer literature regarding conceptualizations of fatigue (Bower et al., 
2014; L. F. Brown & Kroenke, 2009; Hofman et al., 2007; Visser & Smets, 1998).  The 
most recent American Cancer Society (ACS) guidelines define cancer-related fatigue as 
“a distressing, persistent, subjective sense of physical, emotional, and/or cognitive 
tiredness or exhaustion related to cancer and/or cancer treatment that is not proportional 
to recent activity and interferes with usual functioning” (Bower et al., 2014, p. 1843).  
One of the controversies surrounding cancer-related fatigue is that it is often highly 
correlated with psychological distress (Bower et al., 2014; L. F. Brown & Kroenke, 2009; 
L. F. Brown et al., 2013; Visser & Smets, 1998).  A systematic review of 59 studies with 
cancer patients reported that the average sample-size weighted correlations were 
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moderate between fatigue and depression (r = 0.56, 95% CI: 0.54 to 0.58, k = 59) as well 
as fatigue and anxiety (r = 0.46, 95% CI: 0.44 to 0.49, k = 35)  (L. F. Brown & Kroenke, 
2009).  As with any correlation, three possibilities exist: (1) psychological distress causes 
cancer-related fatigue; (2) cancer-related fatigue causes psychological distress; or (3) a 
third factor (e.g., a common etiology) causes both cancer-related fatigue and 
psychological distress (L. F. Brown & Kroenke, 2009; Jacobsen, 2004; Visser & Smets, 
1998).  Longitudinal studies provide the most support for the third possibility; that is, 
cancer-related fatigue and psychological distress are likely separate constructs with a 
common etiology (L. F. Brown et al., 2013; Morrow et al., 2003; Pirl, Greer, Goode, & 
Smith, 2008; Visser & Smets, 1998).   
Prevalence estimates of clinical levels of fatigue in lung cancer patients have 
varied from 37% to 78%, with higher rates in patients with advanced disease (Hickok, 
Morrow, McDonald, & Bellg, 1996; Hopwood & Stephens, 1995; Hürny et al., 1993; 
Okuyama et al., 2001; Tanaka et al., 2002b).  Fatigue in lung cancer patients is often: (1) 
prevalent at diagnosis (Hopwood & Stephens, 1995); (2) exacerbated by treatment (e.g., 
chemotherapy and radiation) (Hickok et al., 1996; Hürny et al., 1993); and (3) worse as 
patients approach death (Hürny et al., 1993; Okuyama et al., 2001).  Increased fatigue in 
lung cancer patients has been associated with increased psychological distress, pain, and 
breathlessness as well as worse performance status and reduced health-related quality of 
life (Hickok et al., 1996; Hürny et al., 1993; Okuyama et al., 2001; Tanaka et al., 2002b).  
 Compared to lung cancer patients, family caregivers of lung cancer patients tend 
to report comparable or increased levels of depressive and anxiety symptoms  (Carmack 
Taylor et al., 2008; Kim, Duberstein, Sörensen, & Larson, 2005; Mellon, Northouse, & 
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Weiss, 2006; Mosher, Champion, et al., 2013).  It is estimated that between 30% and 
50% of family caregivers of lung cancer patients experience clinically significant 
depressive or anxiety symptoms (Carmack Taylor et al., 2008; Kim et al., 2005; Mosher, 
Champion, et al., 2013).  Moreover, longitudinal studies suggest that, for many 
caregivers, psychological distress persists during the months and even years after the 
patient’s diagnosis (Choi et al., 2012; Lambert, Jones, Girgis, & Lecathelinais, 2012).  
Increased psychological distress in caregivers of lung cancer patients is related to 
increased caregiving strain and reduced health-related quality of life (Braun, Mikulincer, 
Rydall, Walsh, & Rodin, 2007; Mellon et al., 2006).  The substantial caregiving demands 
in lung cancer likely contribute to caregivers’ psychological distress (Badr & Taylor, 
2006; Bakas, Lewis, & Parsons, 2001; Mosher, Bakas, & Champion, 2013).  For 
example, caregivers of lung cancer patients often report spending much of their day 
providing the patient with emotional support, monitoring and managing the patient’s 
symptoms, and helping with practical tasks (e.g., driving to medical appointments) 
(Bakas et al., 2001).  Caregivers’ increased psychological distress may also be related to 
their own or others’ smoking behavior (e.g., the patient continues to smoke despite the 
caregiver’s requests to quit) (Badr & Taylor, 2006).  Lastly, many theorize that the 
burden of caregiving may be particularly high in lung cancer, given patients’ poor 
prognosis and severe symptom burden (Carmack Taylor et al., 2008; Hopwood & 
Stephens, 1995; Mosher, Champion, et al., 2013; Spiro, Douse, Read, & Janes, 2008).  
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Dyadic Interventions for Cancer Patients and their Caregivers 
 Randomized controlled trials (RCTs) of dyadic interventions for cancer patients 
and their caregivers have demonstrated small to moderate effects on multiple patient and 
caregiver symptoms (Badr & Krebs, 2013; Baik & Adams, 2011; Li & Loke, 2014; 
Martire et al., 2010; McLean & Jones, 2007; Regan et al., 2012).  The following sections 
will focus specifically on psychosocial dyadic interventions for the symptoms that were 
examined in the current study (i.e., patient and caregiver depressive and anxiety 
symptoms and patient pain, distress related to breathlessness, and fatigue).  
 Numerous RCTs have shown that dyadic interventions for cancer patients and 
their caregivers can decrease depressive and anxiety symptoms (Badger, Segrin, Dorros, 
Meek, & Lopez, 2007; Li & Loke, 2014; L. L. Northouse et al., 2007; Porter et al., 2011).  
A variety of therapeutic approaches (e.g., cognitive-behavioral therapy [CBT], 
interpersonal therapy, education) and modalities (e.g., telephone-delivered, group-based, 
in-person) have been tested, with the majority of interventions including CBT-based 
techniques (e.g., relaxation, cognitive restructuring) delivered in-person by nurses or 
mental health professionals (Badr & Krebs, 2013; Li & Loke, 2014).  A recent meta-
analysis identified 20 RCTs testing dyadic interventions for psychological distress in 
cancer patients and their caregivers (Badr & Krebs, 2013).  The interventions tended to 
produce small, significant reductions in psychological distress for both patients (g = 0.25, 
95% CI: 0.12 to 0.32, k = 17) and their caregivers (g = 0.21, 95% CI: 0.08 to 0.34, k = 12) 
immediately post-intervention.  However, the authors noted that most studies had small 
sample sizes (mean n = 115.00, SD = 77.28) and short follow-up time frames; 
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additionally, few studies included a theoretical framework or examined intervention 
mechanisms.  
In contrast to psychological distress, few RCTs have reported dyadic intervention 
effects on cancer patient pain, distress related to breathlessness, and fatigue (Porter et al., 
2011; Regan et al., 2012).  Concerning pain, one pilot trial tested the efficacy of a 
caregiver-guided coping skills intervention for advanced cancer patients at the end of life 
(N = 78 dyads) (Keefe et al., 2005).  Compared to treatment as usual, patients in the 
intervention group showed no significant improvement in pain post-intervention.  
Conversely, another pilot trial examined a bi-weekly, 6-session relationship enhancement 
intervention for early-stage breast cancer patients and their male partners (N = 14 dyads) 
(Baucom et al., 2009).  Compared to treatment as usual, patients in the intervention group 
reported significantly less pain immediately post-intervention and at a 1 year follow-up.   
To date, only one RCT has reported the effects of a dyadic intervention on cancer 
patient distress related to breathlessness (Porter et al., 2011).  Specifically, Porter et al. 
(2011) tested a telephone-delivered intervention for 233 lung cancer patients and their 
caregivers.  The authors compared 14 sessions of a coping skills program to an education 
and support program.  The results showed that patients in both conditions reported 
reductions in pain and lung cancer symptoms, including distress related to breathlessness.  
Interestingly, the coping skills intervention was most beneficial for dyads with stage II 
and III cancers, whereas the education and support condition was most beneficial for 
dyads with stage I cancers.  The authors noted that coping skills may be more helpful for 
dyads with higher symptom burden (i.e., stage II and III cancers).   
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Lastly, only two RCTs have examined dyadic intervention effects on cancer 
patient fatigue (Badger et al., 2011; Baucom et al., 2009).  First, in a study discussed 
previously, Baucom et al. (2009) conducted a pilot trial of a relationship enhancement 
intervention for breast cancer patients and their partners (N = 14 dyads).  Patients in the 
intervention arm, compared to treatment as usual, reported less fatigue severity 
immediately post-intervention and at a 1 year follow-up.  Second, Badger et al. (2011) 
tested two telephone-delivered psychosocial interventions for prostate cancer survivors 
and their partners (N = 70 dyads).  The authors compared an 8-week interpersonal 
counseling intervention to an 8-week health education attention condition.  The health 
education arm included written materials explaining the role of exercise in reducing 
fatigue.  Patients in the health education arm reported less fatigue (combined severity and 
interference) compared to patients in the interpersonal counseling arm.  In sum, given the 
mixed results and limited number of studies, more research is needed to assess the 
efficacy of dyadic interventions for cancer patient pain, distress related to breathlessness, 
and fatigue.  
 
Individual Interventions for Cancer Patient Pain, Distress Related to Breathlessness, and 
Fatigue 
Few studies have examined dyadic interventions for cancer patient pain, distress 
related to breathlessness, and fatigue; however, numerous studies have tested individual 
psychosocial interventions for these symptoms in cancer patients (Gorin et al., 2012; 
Rueda, Solà, Pascual, & Subirana Casacuberta, 2011).  First, a meta-analysis identified 
38 RCTs that have tested psychosocial interventions for cancer patient pain (Gorin et al., 
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2012).  Most intervention trials compared a combined psychoeducation and coping skills 
intervention to a usual care control group.  The interventions tended to produce moderate, 
significant reductions in both pain severity (g = 0.34, 95% CI: 0.23 to 0.46, k = 38) and 
pain interference (g = 0.40, 95% CI: 0.21 to 0.60, k = 4) over a median follow-up of 6 
weeks (SD = 12.4).  Additionally, studies that monitored treatment delivery tended to 
yield even larger effects.   
Concerning distress related to breathlessness, a meta-analysis identified three 
RCTs that have tested nurse-delivered breathlessness management interventions for lung 
cancer patients (Rueda et al., 2011).  These studies included relaxation techniques that 
targeted both the physiological and emotional aspects of breathlessness (Barton, English, 
Nabb, Rigby, & Johnson, 2010; Bredin et al., 1999; Corner, Plant, A'hern, & Bailey, 
1996).  Compared to usual care, the interventions tended to produce significant 
reductions in distress related to breathlessness.  However, these results should be 
interpreted cautiously due to the small sample sizes of these studies (range = 22 to 109).   
Lastly, a meta-analysis identified 57 RCTs that have tested non-pharmacological 
therapies for fatigue (both severity and interference) in cancer patients (Kangas, 
Bovbjerg, & Montgomery, 2008).  The results suggested that exercise (k = 16) and 
psychosocial (k = 41, predominately CBT-based) interventions produced small to 
moderate reductions in fatigue immediately post-intervention (d = -0.41, 95% CI: -0.60 to 
-0.23 and d = -0.31, 95% CI: -0.40 to -0.25, respectively), with no significant differences 
between the two intervention types.  Consistent with these findings, a more recent meta-
analysis identified 48 RCTs testing exercise interventions for fatigue in cancer patients 
and reported a moderate reduction in fatigue immediately post-intervention (d = -0.31, 
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95% CI: -0.40 to -0.22) (J. C. Brown et al., 2011).  It is important to note that fatigue was 
not measured consistently in these studies, and few studies differentiated fatigue 
interference from severity.  Additionally, some of these studies included lung cancer 
patients along with other cancer types; however, none of the studies in these meta-
analyses targeted lung cancer patients specifically.  Since these two meta-analyses, Chan, 
Richardson, and Richardson (2011) conducted an RCT testing a psychoeducational 
intervention combined with relaxation techniques for 140 lung cancer patients 
undergoing radiation therapy.  The results showed that, compared to usual care, patients 
in the intervention arm reported less fatigue severity at 3 weeks post-intervention.  Due to 
high attrition, however, intervention effects were not examined at 6 or 12 weeks post-
intervention.      
 
Associations Between Intervention Components and Outcomes in Cancer Patients 
Understanding how psychosocial interventions work (e.g., intervention 
mechanisms, effective components) is a crucial yet often overlooked step in developing 
efficacious and cost-effective interventions (Czaja et al., 2003; C. W. Given et al., 2010; 
Kazdin, 2007).  However, there are numerous methodological challenges related to 
identifying effective components of complex psychosocial interventions that target 
multiple symptoms (Andersen et al., 2007; Czaja et al., 2003; C. W. Given et al., 2010).  
Examining the main effects (i.e., intervention vs. control) of a complex intervention 
provides data regarding the intervention’s overall effectiveness; however, such analyses 
do not explain which components of the intervention contributed to the effect (Czaja et 
al., 2003; C. W. Given et al., 2010).  The most stringent component analysis studies 
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compare two interventions with only one component varying between groups (Kazdin, 
2007).  Single-component interventions can answer important questions regarding 
causality (Kazantzis et al., 2010; Kazdin, 2007).  For example, numerous dismantling 
studies have explored the role of homework assignments in CBT for various disorders 
(Blanchard et al., 1991; Carroll, Nich, & Ball, 2005; Neimeyer & Feixas, 1990).  Meta-
analytic results suggest that including homework assignments in CBT interventions 
produces better post-intervention outcomes when compared to the same intervention 
without homework assignments (d = 0.48, 95% CI: 0.25 to 0.71, k = 9) (Kazantzis et al., 
2010).  However, single-component studies are rarely conducted with medical 
populations due to theoretical concerns (e.g., is CBT without homework actually CBT?) 
and feasibility issues (e.g., insufficient power to detect between group differences) (Czaja 
et al., 2003; Kazantzis et al., 2010).  
An alternative method for identifying effective intervention components is to 
design interventions within a theoretical framework that hypothesizes how specific 
components should be related to specific outcomes (Czaja et al., 2003; C. W. Given et al., 
2010; Kazdin, 2007).  Some dyadic interventions for cancer patients and their caregivers 
are designed based on a theoretical framework (Badr & Krebs, 2013); however, to date, 
none of these studies have reported results from component-outcome analyses.  
In non-dyadic psychosocial interventions for cancer patients, five studies have 
reported associations between intervention components and outcomes (Andersen et al., 
2007; Chan et al., 2012; Cohen & Fried, 2007; Matthews et al., 2012; Tremblay et al., 
2009).  Two of the studies examined components of CBT-based interventions for 
insomnia in breast cancer patients (Matthews et al., 2012; Tremblay et al., 2009).  These 
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studies showed that greater adherence to intervention components (e.g., prescribed rise 
time, total time in bed) was related to less fatigue and improved sleep quality.  The 
remaining three studies explored component-outcome associations for some of the 
symptoms examined in the current project, including psychological distress and 
breathlessness (Andersen et al., 2007; Chan et al., 2012; Cohen & Fried, 2007).   
First, Andersen et al. (2007) examined data from a 12-month RCT testing a 
group-based psychosocial intervention for 227 breast cancer survivors.  Based on a 
biobehavioral theoretical framework (Andersen, Kiecolt-Glaser, & Glaser, 1994), specific 
intervention components (e.g., relaxation exercises, assertive communication) were 
hypothesized to improve psychological distress and physical symptoms.  Intervention 
components were measured using self-report of coping skills practice.  Physical symptom 
severity was assessed based on a nurse-rated symptom measure that included 22 body 
categories (e.g., neck, stomach).  The results showed that those in the intervention group 
who more frequently practiced relaxation exercises reported less psychological distress 
post-intervention.  Moreover, those with greater symptom burden at baseline were more 
likely to practice relaxation exercises daily and had greater nurse-rated global symptom 
reduction post-intervention.  Other intervention components also significantly predicted 
global symptom reduction, such as assertive communication with treatment providers and 
increased group cohesion. 
Second, Cohen and Fried (2007) compared nine sessions of a CBT-based group 
intervention to nine sessions of a relaxation group for 114 breast cancer patients.  
Homework was assigned in both groups and adherence to the assignments was assessed 
based on self-report.  Interestingly, those in the relaxation group were more adherent to 
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assignments than those in the CBT group.  However, increased adherence to home 
practice in both groups was significantly related to post-intervention reductions in 
psychological distress, sleep difficulties, and fatigue. 
Third, Chan et al. (2012) conducted a secondary analysis of an RCT testing two 
sessions of a psychoeducation and progressive muscle relaxation (PMR) program for 
symptom management in advanced lung cancer patients receiving radiation therapy.  
Patients completed the first intervention session one week before starting radiation 
therapy and completed the second session three weeks later.  PMR practice was recorded 
using a self-report relaxation diary that patients were encouraged to complete every day.  
In the intervention arm (N = 70), patients who practiced PMR more frequently reported 
less breathlessness intensity and less fatigue at 12 weeks post-intervention.  However, 
PMR practice was not related to post-intervention anxiety or performance status. 
Overall, there is some support for associations between intervention components 
and outcomes in psychosocial interventions for cancer patients (Andersen et al., 2007; 
Chan et al., 2012; Cohen & Fried, 2007; Matthews et al., 2012; Tremblay et al., 2009).  
However, very few studies have examined these associations and methodological 
differences (e.g., intervention design) should be noted.  Moreover, only one study 
(Andersen et al., 2007) specified a theoretical framework to guide the component-
outcome analyses.  Thus, more theory-driven research is needed to identify the most 
effective components of psychosocial symptom management interventions for cancer 
patients.     
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Social Cognitive Theory and Associations Between Intervention Components and 
Outcomes 
Social Cognitive Theory (SCT) provides a theoretical framework for 
understanding how specific intervention components (e.g., coping skills practice) may be 
related to decreased symptoms in a dyadic intervention for lung cancer patients and their 
caregivers (Bandura, 1986, 2004).  The following sections will describe SCT and then 
discuss how practicing specific coping strategies is theorized to improve specific 
outcomes. 
Founded on reciprocal determinism, SCT states that behavior, personal factors, 
and environmental influences are dynamically and reciprocally related such that a person 
influences his or her environment and vice versa (Bandura, 1986, 2004).  SCT posits a 
core set of determinants and respective mechanisms that explain how people translate 
knowledge into behavior change (Bandura, 1986, 2004).  The specific core determinants 
include the following: (1) knowledge of benefits/risks associated with a behavior; (2) 
self-efficacy that one can bring about a desired outcome; (3) expectations of 
costs/benefits of a behavior; (4) goals, plans, and strategies for implementing a desired 
behavior; and (5) facilitators and impediments to a desired behavior (Bandura, 2004). 
 Each of the determinants of behavior change occurs within a social environment 
where social support and behavioral modeling are of central importance (Bandura, 1986, 
2004).  In the context of cancer, for example, a patient’s self-efficacy for managing his or 
her anxiety may be enhanced through receiving encouragement from a family member 
(i.e., social support) and watching the family member use adaptive coping skills (i.e., 
behavioral modeling).  Substantial research has supported the efficacy of SCT-based 
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components (e.g., enhancing self-efficacy, goal setting) in psychosocial interventions for 
cancer patients (Faller et al., 2013; Graves, 2003).  For example, a meta-analysis of 
psychosocial interventions for improving cancer patients’ quality of life found that 
interventions with more SCT components produced significantly larger effect sizes than 
interventions with fewer or no SCT components (Z = 3.72, k = 38) (Graves, 2003). 
According to SCT, it is crucial that the core determinants of behavior change be 
incorporated into interventions in order for the patient and caregiver to regularly 
implement and benefit from coping skills (Bandura, 1986, 2004).  Specifically, the 
patient-caregiver dyad should first receive psychoeducation regarding how the symptom 
is conceptualized and how the specific coping strategy may reduce the symptom (i.e., 
gain knowledge about the behaviors and set outcome expectations).  Following, each 
member of the dyad should practice the skill during and outside of the session in order to 
increase their self-efficacy for using the skill.  Lastly, the dyad should be instructed to set 
goals, plans, and strategies for implementing the coping skill as well as discuss possible 
obstacles to using the skill (i.e., goals and facilitators/impediments).  It is important to 
note that the SCT determinants of behavior mutually influence each other over time 
(Bandura, 1986, 2004).  For example, as the dyad experiences symptom reduction with a 
specific skill, their self-efficacy for managing that symptom may increase.  Thus, they 
may use the skill more often and experience even greater symptom reduction.  Moreover, 
the dyad members may model the coping skill to each other and reinforce each other’s 
practice of the skill (Bandura, 1986, 2004).  Compared to individual interventions, dyadic 
interventions provide an optimal context for testing SCT-based intervention components 
because the intervention includes social support and modeling from a close family 
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member (Bandura, 1986, 2004).  In sum, a central hypothesis derived from SCT is that as 
coping skills practice increases, patient and caregiver symptoms will decrease.  The 
following sections describe the theoretical pathways through which specific coping skills 
may reduce specific symptoms for patients and caregivers.  
According to SCT, depressive and anxiety symptoms are the result of an 
interaction between thoughts, emotions, and behaviors (Bandura, 1986).  Consistent with 
this notion, in CBT, depressive and anxiety symptoms are theorized to be developed and 
maintained through maladaptive thought patterns (e.g., automatic thoughts) and 
maladaptive behaviors (e.g., avoidance) (Beck & Weishaar, 1989; Dobson, 2009).  Thus, 
CBT-based intervention components are designed to change maladaptive thoughts and 
behaviors related to symptoms through specific coping strategies, such as cognitive 
restructuring, relaxation techniques, and assertive communication (Beck & Weishaar, 
1989; Dobson, 2009). 
First, cognitive restructuring is one strategy used to reduce depressive and anxiety 
symptoms by identifying maladaptive thoughts and replacing them with more accurate, 
adaptive thoughts (Beck & Weishaar, 1989).  According to Beck’s cognitive theory, 
depressive and anxiety symptoms are related to underlying dysfunctional schemas that 
produce negative automatic thoughts (Beck & Weishaar, 1989).  These automatic 
thoughts involve unrealistic, negative interpretations of events, leading to mood 
disturbance (Beck & Weishaar, 1989; Dobson, 2009).  Thus, as the dyad practices 
cognitive restructuring, their depressive and anxiety symptoms should decrease, 
reflecting a change in their automatic thoughts (Beck & Weishaar, 1989; Dobson, 2009). 
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Second, relaxation techniques (e.g., pursed-lips breathing, guided imagery, 
noticing sounds and thoughts) are included in CBT as behavioral strategies for reducing 
depressive and anxiety symptoms through multiple pathways, such as reduced emotional 
arousal and distraction (Beck & Weishaar, 1989; Dobson, 2009).  Specifically, relaxation 
techniques may reduce emotional arousal by counteracting the stress response (i.e., fight 
or flight response) through slowed breathing, reduced muscle tension, and lowered blood 
pressure (Andersen et al., 1994; Benson & Klipper, 1992; Dobson, 2009).  Moreover, if a 
patient or caregiver is experiencing anxiety from thinking about the cancer, practicing 
relaxation exercises can serve as a distraction from negative thoughts and, thus, lead to 
improved mood (Badger et al., 2007; Porter et al., 2011).  In contrast to the other coping 
skills, patients and caregivers may experience immediate reductions in their distress when 
performing relaxation exercises, which may enhance their sense of control and self-
efficacy for managing emotional distress.    
Lastly, in CBT, assertive communication skills are also incorporated for reducing 
depressive and anxiety symptoms (Beck & Weishaar, 1989; Dobson, 2009).  Specifically, 
assertive communication skills are taught as a means of effectively eliciting social 
support, communicating thoughts and feelings about cancer, and obtaining medical 
attention for symptoms (Badr & Taylor, 2006; Keefe et al., 2005).  Depressive and 
anxiety symptoms may be reduced as the dyad improves their ability to communicate 
with each other and their medical team (Porter et al., 2011).  
CBT for pain management includes the same coping strategies discussed above 
(Keefe, 1996; Morley, Eccleston, & Williams, 1999); however, there are some 
differences regarding the mechanisms through which these skills may reduce pain (Keefe, 
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Somers, & Abernethy, 2010).  According to CBT for pain management and the Gate 
Control Theory of Pain, pain is a complex interaction between the patient’s 
pathophysiology and his or her thoughts, feelings, and behaviors (Beck & Weishaar, 
1989; Dobson, 2009; Keefe, 1996; Melzack & Wall, 1965).  The Gate Control Theory of 
Pain posits that a modifiable “gating system” in the central nervous system controls the 
transmission of pain signals from the peripheral nerve.  The pain experience can thus 
change depending on internal and external factors: various factors can either “open the 
gate” (i.e., allow pain signals) or “close the gate” (i.e., stop pain signals).  For example, 
emotional distress has been shown to “open the gate” and, thus, increase the amount of 
pain a patient experiences (Melzack & Wall, 1965; Turner, Jensen, Warms, & Cardenas, 
2002).  By using specific coping strategies, it is theorized that patients can “close the 
gate” and, thus, reduce the severity of their pain (Keefe et al., 2010; Melzack & Wall, 
1965).   
Some of the specific coping strategies used in CBT for pain management include 
cognitive restructuring, relaxation exercises, and assertive communication (Keefe, 1996; 
Keefe et al., 2010; Morley et al., 1999).  First, cognitive restructuring begins by helping 
patients become aware of maladaptive thoughts related to pain (e.g., “I will feel less pain 
if I just stay in bed today”).  Following, the patient is instructed to develop more accurate 
and/or adaptive thoughts related to pain (e.g., “I will feel less pain if I stay active without 
overextending myself”).  Adaptive thoughts are theorized to reduce pain severity 
indirectly through mechanisms such as reduced emotional distress and increased physical 
activity (Beck & Weishaar, 1989; Dobson, 2009; Keefe, 1996; Melzack & Wall, 1965).  
Second, relaxation exercises (e.g., pursed lips breathing, guided imagery) can decrease 
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pain severity by reducing muscle tension and psychological distress, which in turn may 
increase the patient’s sense of control and self-efficacy for managing his or her pain 
(Keefe, 1996; Morley et al., 1999).  Moreover, these exercises can also distract the 
patient from his or her pain during a pain flare-up.  Lastly, assertive communication can 
decrease patient pain via numerous pathways (Keefe, 1996).  First, a patient can learn to 
improve communication with his or her healthcare provider when additional pain control 
is needed (Keefe et al., 2005).  Second, a patient can use assertive communication to 
elicit support from his or her caregiver, including emotional support or assistance with 
activities that may exacerbate pain (Porter et al., 2011).  
Coping skills taught in CBT may also reduce patient distress related to 
breathlessness (Barton et al., 2010; Bredin et al., 1999; Portenoy et al., 1994).  As with 
the other symptoms, it is important to note the reciprocal relationship between the 
patient’s breathlessness and his or her thoughts, emotions, and behaviors (Porter et al., 
2011).  Although a patient may continue to experience frequent breathlessness, his or her 
distress related to this symptom may be reduced through cognitive restructuring, 
relaxation techniques, and assertive communication (Barton et al., 2010; Corner et al., 
1996; Porter et al., 2011).  First, cognitive restructuring may reduce distress by 
identifying the patient’s negative thoughts related to his or her breathlessness (e.g., “I 
won’t be able to catch my breath”) and replacing them with more adaptive thoughts (e.g., 
“I have dealt with breathlessness before; I can do it again”).  Second, some relaxation 
exercises have produced significant reductions in distress related to breathlessness 
(Barton et al., 2010; Greer et al., 2015).  As noted above, patients may experience 
immediate reductions in their distress when performing relaxation exercises, which likely 
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enhances their sense of control and self-efficacy for managing breathlessness.  Finally, 
assertive communication may also reduce distress related to breathlessness through 
helping the patient communicate thoughts and feelings about his or her breathing to the 
caregiver and medical team, which may lead to action steps (e.g., oxygen use).  
Lastly, CBT-based coping skills may reduce the amount of interference a patient 
experiences from fatigue (Berger, Gerber, & Mayer, 2012; Gielissen, Verhagen, & 
Bleijenberg, 2007; Kangas et al., 2008).  Consistent with the other symptoms discussed, it 
is crucial to note the reciprocal relationship between a patient’s fatigue and his or her 
thoughts, emotions, and behaviors (Bandura, 2004; Dobson, 2009).  In CBT for cancer-
related fatigue (Gielissen, Verhagen, Witjes, & Bleijenberg, 2006), fatigue is often 
conceptualized as being caused by cancer and/or its treatment; in contrast, other factors 
(e.g., thoughts, emotions, and behaviors) are posited to perpetuate the interference a 
patient experiences from his or her fatigue.  Specific coping skills taught in CBT for 
cancer-related fatigue include cognitive restructuring, relaxation techniques, and assertive 
communication (Gielissen et al., 2006; Kangas et al., 2008).  First, cognitive restructuring 
may be used to challenge a patient’s catastrophic thinking about the negative impact of 
fatigue on his or her ability to function (e.g., “I’m helpless when I’m this fatigued; I can’t 
get anything done”).  A more adaptive way of thinking about fatigue is posited to 
increase the patient’s sense of control and self-efficacy for managing fatigue (Gielissen et 
al., 2006).  In turn, the patient may increase his or her activity (both physical and social) 
and, thus, experience less interference from this symptom.  Second, relaxation techniques 
are also posited to reduce fatigue interference by immediately reducing distress related to 
fatigue, thus enhancing the patient’s sense of control and self-efficacy for managing 
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fatigue (Kangas et al., 2008).  Relaxation techniques can also help a patient initiate sleep, 
thereby reducing fatigue.  Lastly, assertive communication may reduce a patient’s fatigue 
interference by helping the patient effectively solicit social and practical support from his 
or her caregiver (Berger et al., 2012).  For example, a patient may request help with 
certain activities of daily living that may be difficult to complete when fatigued.
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PRESENT STUDY 
  In sum, little research has explored associations between intervention 
components and outcomes in individual or dyadic interventions for cancer populations; 
thus, the degree to which certain components of these interventions predict improved 
health outcomes for cancer patients and their caregivers is largely unknown.  Identifying 
effective intervention components will inform the development of more cost-effective 
and efficacious interventions (Czaja et al., 2003; Kazdin, 2007).  The present study 
examined associations between coping skills practice and symptom change in a telephone 
symptom management intervention delivered concurrently to symptomatic lung cancer 
patients and their family caregivers.  The intervention was guided by SCT (Bandura, 
1986, 2004) and focused on teaching patient-caregiver dyads specific coping skills, 
including relaxation exercises (i.e., noticing sounds and thoughts, guided imagery, pursed 
lips breathing), cognitive restructuring, and assertive communication.  Thus, based on 
SCT (Bandura, 1986, 2004) and previous research (Andersen et al., 2007; Chan et al., 
2012; Cohen & Fried, 2007), the specific aims and hypotheses of this study were as 
follows: 
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Aim 1.  To examine the extent to which patients’ between-session coping skills practice 
(i.e., noticing sounds and thoughts, guided imagery, pursed lips breathing, cognitive 
restructuring, and assertive communication) was related to their symptoms (i.e., pain 
severity, distress related to breathlessness, fatigue interference, and depressive and 
anxiety symptoms) following a dyadic intervention for lung cancer patients and their 
family caregivers. 
Hypothesis 1.1: Patients’ increased coping skills practice during the intervention will be 
related to reduced pain severity at 2 and 6 weeks post-intervention.   
Hypothesis 1.2: Patients’ increased coping skills practice during the intervention will be 
related to reduced distress related to breathlessness at 2 and 6 weeks post-intervention.   
Hypothesis 1.3: Patients’ increased coping skills practice during the intervention will be 
related to reduced fatigue interference at 2 and 6 weeks post-intervention.   
Hypothesis 1.4: Patients’ increased coping skills practice during the intervention will be 
related to reduced depressive symptoms at 2 and 6 weeks post-intervention.   
Hypothesis 1.5: Patients’ increased coping skills practice during the intervention will be 
related to reduced anxiety symptoms at 2 and 6 weeks post-intervention.   
Aim 2.  To examine the extent to which caregivers’ between-session coping skills 
practice (i.e., noticing sounds and thoughts, guided imagery, pursed lips breathing, 
cognitive restructuring, and assertive communication) was related to their depressive and 
anxiety symptoms following a dyadic intervention for lung cancer patients and their 
family caregivers. 
Hypothesis 2.1: Caregivers’ increased coping skills practice during the intervention will 
be related to reduced depressive symptoms at 2 and 6 weeks post-intervention.   
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Hypothesis 2.2: Caregivers’ increased coping skills practice during the intervention will 
be related to reduced anxiety symptoms at 2 and 6 weeks post-intervention.
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METHODS 
Sample Recruitment and Selection 
All study procedures were approved by the Indiana University Institutional 
Review Board.  Lung cancer patients and their family caregivers were recruited from 
three study sites: the Indiana University Simon Cancer Center (IUSCC), Eskenazi 
Hospital, and the Roudebush VA Medical Center.  A trained research assistant first 
reviewed electronic medical records in order to identify potentially eligible lung cancer 
patients.  Eligible lung cancer patients were 18 years of age or older and at least 3 weeks 
post-diagnosis of small cell or non-small cell lung cancer.  The initial weeks following a 
cancer diagnosis are often stressful (e.g., frequent medical appointments, adjusting to the 
diagnosis); thus, we only approached patients who were at least 3 weeks post-diagnosis.  
Additionally, we recruited patients of all stages because lung cancer patients experience 
physical and psychological symptoms across the disease trajectory (Hopwood & 
Stephens, 1995; Hopwood & Stephens, 2000; Kurtz et al., 2002; Rolke et al., 2008; 
Zabora et al., 2001).  Given that the intervention aimed to reduce symptoms, we enrolled 
patients with at least one moderate to severe symptom (see details below), regardless of 
their treatment (with the exception of hospice care), time since diagnosis, or disease 
stage.
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Patients were not eligible if they: (1) participated in a qualitative study that 
involved providing feedback on the current intervention materials, or (2) were receiving 
hospice care.  Those receiving hospice care were excluded to reduce contamination in the 
control condition, as hospice generally involves the receipt of extensive supportive care 
services.  
Following medical record review, the patient’s oncologist was consulted 
regarding the patient’s eligibility.  Next, the oncologist or an authorized representative 
(e.g., a nurse) introduced the research assistant to the patient before or after an oncology 
clinic visit.  The patient was then asked if he or she was currently participating in a 
psychosocial study.  If the patient was not enrolled in another psychosocial study, the 
research assistant proceeded with the consent process and described the study as one 
exploring the use of telephone support programs for lung cancer patients and their family 
members.  Then the research assistant asked the patient if he or she had a family 
caregiver or close friend who provided him or her with support (e.g., driving to 
appointments, emotional support).  Next, the patient was asked if the identified caregiver 
lived with him or her or had visited at least two times per week over the past month.  
Living with the patient or frequent in-person contact was required given that the 
intervention involved the patient and caregiver jointly participating via speakerphone.  
When multiple caregivers were identified, the patient was asked to select the primary 
caregiver (i.e., the family member or friend who provided the majority of his or her 
unpaid, informal care).  Patients who identified an eligible caregiver and were interested 
in the study were then given a consent form, an authorization form, and a study brochure.  
These materials were carefully reviewed, including the study procedures and health 
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information (i.e., date of diagnosis, cancer stage, and cancer treatments) that would be 
collected from the patient’s medical record should he or she agree to participate.  The 
patient was also informed that participation required a working cell phone or home phone 
service.  The patient was encouraged to ask questions and, after all questions were 
answered, he or she was invited to complete a screening assessment. 
The first step of the screening assessment was the verbal administration of a 
cognitive screener (Callahan, Unverzagt, Hui, Perkins, & Hendrie, 2002).  If the patient 
made 3 or fewer errors on the cognitive screener, then he or she completed a 5-minute 
assessment that consisted of five self-report symptom measures (see Measures section for 
details).  In order to be eligible for the study, the patient had to endorse at least one of 
five symptoms at a moderate to severe level, including anxiety, depressive symptoms, 
pain, fatigue, or breathlessness.  These five symptoms were chosen because they are 
highly prevalent and tend to cluster together in lung cancer patients (Dudgeon et al., 
2001; Hopwood & Stephens, 1995; Kurtz et al., 2002; Rolke et al., 2008; Zabora et al., 
2001); additionally, all of these symptoms are amenable to non-pharmacological 
intervention (Badr & Krebs, 2013; Gorin et al., 2012; Li & Loke, 2014; Rueda et al., 
2011).  During the screening assessment, the research assistant used his or her clinical 
judgment to assess for additional exclusion criteria, including: (1) lack of adequate 
English fluency; and (2) significant psychiatric or cognitive impairment (e.g., active 
psychosis).  
Following the screening assessment, written informed consent was obtained from 
interested and eligible patients.  Additionally, consenting patients were asked to provide 
written permission for the study team to collect information from their medical records, 
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including the date of the lung cancer diagnosis, the lung cancer type (i.e., small cell or 
non-small cell) and stage, and treatments received (i.e., surgery, chemotherapy, radiation, 
chemoradiation).   
Following the patient consent process, the caregiver was approached if he or she 
was present during the clinic visit.  The caregiver was presented with the study brochure 
and consent and authorization forms.  The study was reviewed with the caregiver and any 
questions were answered.  Eligible caregivers met the following criteria: (1) were at least 
18 years of age; (2) lived with the patient or visited him or her in-person at least two 
times per week over the past month; (3) had adequate English fluency; and (4) had 
working phone service.  Caregivers were considered ineligible if they: (1) were 
participating in another psychosocial study; (2) participated in a qualitative study that 
involved providing feedback on the current intervention materials; or (3) displayed 
significant psychiatric or cognitive impairment (e.g., active psychosis, dementia) in the 
judgment of the oncologist or trained research assistant.  
After a discussion of the study, interested caregivers provided written informed 
consent.  If the caregiver was not present in clinic, the patient was asked if he or she 
could hand-deliver the study materials to the caregiver or if the study team may mail the 
materials to the caregiver.  Following, a research assistant contacted the caregiver via 
telephone to conduct the consent process.  If the patient refused to provide contact 
information for the caregiver or the caregiver refused to participate, both the patient and 
caregiver were considered ineligible for the study.  Lastly, if patients or caregivers 
refused to participate, they were asked if they would be willing to provide their reason for 
nonparticipation, age, and gender.  Additionally, if caregivers refused, they were asked if 
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they would be willing to provide the nature of their relationship to the patient (e.g., 
spouse, sibling).   
 
Procedures 
Baseline assessments were conducted via telephone with the patient and caregiver 
participating separately.  The assessment took up to 40 minutes to complete and included 
demographic questions and symptom measures.  Additional measures were also 
administered (e.g., caregiving strain, quality of life); however, only measures analyzed in 
the current study are described in the following sections. 
 After the baseline assessment, patient-caregiver dyads were assigned to either the 
intervention arm or an attention control arm using a stratified block randomization 
scheme.  The randomization scheme was chosen to balance groups based on patient 
gender and performance status (i.e., ECOG scores 0 or 1 vs. > 2) (Oken et al., 1982).  
Groups were stratified based on patient gender given that women tend to report more 
physical symptom distress and anxiety and depressive symptoms than men (Hagedoorn et 
al., 2008; Hirsh et al., 2006; Riley et al., 2001).  Additionally, groups were stratified 
based on performance status to ensure that the groups were similar with respect to cancer 
treatment, given that lung cancer treatment decisions are often made based on patient 
performance status (Pfister et al., 2004). 
 Telephone-delivered symptom management (TSM) was a manualized SCT-based 
intervention that involved a blend of cognitive-behavioral and emotion-focused strategies 
for the treatment of patient and caregiver depressive symptoms and anxiety as well as the 
management of patient physical symptoms (D. H. Barlow, 2014; J. Barlow, Wright, 
33 
 
Sheasby, Turner, & Hainsworth, 2002; Jacobsen, Donovan, Swaine, & Watson, 2006; 
Nield, Hoo, Roper, & Santiago, 2007; L. L. Northouse, Katapodi, Song, Zhang, & Mood, 
2010; Porter et al., 2009; Porter et al., 2011).  Each TSM session incorporated the SCT 
determinants of behavior change (Bandura, 1986, 2004).  Specifically, the patient-
caregiver dyad received psychoeducation regarding the cognitive-behavioral model of 
symptoms and how specific coping strategies may reduce the symptoms (i.e., knowledge 
about behaviors and outcome expectations).  Additionally, each member of the dyad was 
encouraged to practice the coping skills during and outside of the sessions in order to 
increase their self-efficacy for using the skills.  The dyad was also instructed to set goals 
and devise strategies for implementing the coping skills as well as discuss possible 
obstacles to using the skills (i.e., goals and facilitators/impediments).  Lastly, they were 
encouraged to practice some of the coping skills together (i.e., modeling behavior and 
receiving social support).    
Before the first session, each dyad member assigned to TSM received a notebook 
in the mail that included an appointment reminder sheet, calendar, handouts for each 
session, between-session coping skills practice reminders and tracking sheets, and a CD 
with guided practices for each of the three relaxation exercises.  Patients and caregivers 
participated in the intervention concurrently via speakerphone.  If the dyad did not have 
access to a speakerphone, they were sent one via mail.  TSM was delivered in four, 45-
minute weekly phone sessions by licensed clinical social workers with experience 
working with medical populations.  The social workers received initial training in the 
intervention and weekly supervision by the PI who is a clinical psychologist.  Moreover, 
the PI conducted intervention fidelity checks on 53% of the sessions; the average fidelity 
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rating was 97.5%.   Intervention components were equally focused on patient and 
caregiver concerns, with the rationale for each coping skill tailored to the symptoms 
reported by the patient and caregiver during each session.   
Each of the four TSM sessions followed a similar structure.  First, during the first 
session, the therapist began by introducing herself and establishing rapport with the dyad, 
whereas during sessions 2, 3, and 4, the therapist began by asking for updates on the 
cancer and its treatment and assessing between-session practice of the coping skills.  
Second, patients and caregivers completed brief self-report measures of their symptoms 
(i.e., patient and caregiver depressive and anxiety symptoms and patient pain, fatigue, 
and breathlessness) over the past week.  Third, one or more coping skills were introduced 
and the rationale for the skill was tailored to the dyad’s symptoms.  During sessions 1, 2, 
and 3, the between-session coping skills practice for the next week was discussed.  
Lastly, during session 4, a plan for continued coping skills practice was developed.  The 
following sections provide a more detailed description of the four sessions.   
 The first session began with the therapist building rapport with the dyad.  The 
therapist asked general questions about their lives (e.g., employment, family) and the 
patient’s cancer (e.g., date of diagnosis, treatment history).  Following, the therapist 
provided a rationale for the intervention and an overview of the sessions.  Next, the 
cognitive-behavioral model of symptoms was presented, noting how lung cancer and its 
treatment can impact the dyad’s thoughts, feelings, activities, and physiological 
responses.  Each dyad member was asked to describe one key change in any of these 
areas since the lung cancer diagnosis.  Relaxation was then introduced as an important 
skill for coping with physical symptoms as well as emotional distress.  The rationale for 
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the relaxation exercises was then tailored to the dyad’s symptoms.  For example, if the 
patient was reporting distressing pain, relaxation was discussed as a means of reducing 
muscle tension and distracting oneself from pain.  Three types of relaxation were 
described and practiced during the session, including noticing sounds and thoughts (a 
mindfulness exercise), guided imagery, and pursed lips breathing.  For between-session 
practice, the dyad was instructed to listen to a CD that guided them through the three 
relaxation exercises at least once per day.   
The therapist began the second session by reviewing the between-session practice 
of the relaxation skills, including any barriers to relaxation, and assessed the dyad’s 
symptoms over the past week.  Following, a rationale for examining distressing thoughts 
was presented.  Specifically, the therapist explained that everyone has thoughts 
constantly going through their minds, known as automatic thoughts.  Some automatic 
thoughts are helpful and true, whereas others can be unhelpful or not true.  Identifying 
and examining automatic thoughts was described as a way to understand their mood and 
cope more effectively with lung cancer and symptoms.   
The patient was then asked to think of a challenging event related to the lung 
cancer that happened over the past week.  The therapist assisted the patient in identifying 
thoughts and emotions related to the event.  Using a handout, the therapist helped the 
patient to determine whether the thoughts were true or realistic.  If the thoughts were true, 
the patient decided whether they pertained to controllable or uncontrollable 
circumstances.  The therapist then directed the patient to one of three handouts, 
depending on the nature of the thoughts (i.e., (1) unrealistic thought, (2) true thought 
about a controllable situation, or (3) true thought about an uncontrollable situation).  
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First, if the thought was unrealistic, cognitive restructuring was practiced.  Specifically, 
the therapist helped the patient identify automatic thoughts about the event and then 
gather evidence for and against the thoughts.  Following, the therapist assisted the patient 
in developing a more adaptive thought (i.e., one that considers all of the evidence and 
leads to less distress).  Alternatively, if the patient was having true thoughts about a 
controllable situation (e.g., “I am in a lot of pain”), problem-solving techniques were 
presented, and a plan for addressing the situation was developed.  Finally, if the patient 
was having true thoughts about an uncontrollable situation (e.g., “My disease is 
progressing”), self-soothing and emotion-focused strategies (e.g., relaxation, enjoyable 
activities, emotional disclosure to others) were suggested and scheduled.   
After the patient completed the exercise, the therapist repeated these steps with 
the caregiver (i.e., examining thoughts related to the patient’s lung cancer from the past 
week and using one of the three coping strategies to address these thoughts).  The 
therapist then referred to handouts and explained any coping strategies that were not 
already discussed with the dyad (i.e., cognitive restructuring, problem-solving, or self-
soothing/emotion-focused strategies).  For between-session practice, the dyad was 
instructed to use the relaxation CD at least once per day.  Additionally, they were asked 
to each write down a few thoughts when they had strong emotions during the week.  
Using a handout, they were asked to practice the appropriate coping strategy based on the 
type of thought (i.e., true vs. untrue) and/or situation (i.e., controllable vs. 
uncontrollable).  
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The therapist began the third session by reviewing the between-session practice of 
the relaxation skills and use of skills from the prior session for addressing thoughts.  Then 
the therapist assessed the dyad’s symptoms over the past week.  Subsequently, an 
overview of assertive communication was provided, and each member of the dyad 
identified challenges in communicating with the other dyad member regarding the lung 
cancer (e.g., discussion of patient symptoms or medical treatment decisions).  Then, 
while referring to handouts, the therapist provided specific instruction in communicating 
thoughts and feelings in a direct, honest, and respectful manner as well as listening skills.  
Each dyad member selected a topic and practiced assertive communication with the other 
dyad member, including expression of thoughts and feelings.  The therapist provided 
feedback and asked each dyad member to provide feedback to each other.  Then each 
dyad member noted a topic to discuss with the other dyad member during the coming 
week.  For between-session practice, the dyad was instructed to do the following: (1) use 
the relaxation CD at least once per day, (2) write down a few thoughts when they 
experienced strong emotions and follow the handout describing the appropriate coping 
strategy for addressing these thoughts, and (3) practice using the assertive communication 
skills at least once with each other.  The use of assertive communication with other 
individuals (e.g., the doctor, other family members) was also encouraged.  
 The fourth session began by reviewing the between-session practice of the 
relaxation skills, skills for addressing thoughts, and assertive communication.  Then the 
therapist assessed the dyad’s symptoms over the past week.  Next, scheduling pleasurable 
activities was discussed.  Specifically, the therapist noted how lung cancer and its 
treatment can impact the dyad’s valued and enjoyable activities.  Each dyad member 
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wrote down three activities that he or she enjoyed and was able to do and selected one 
activity to do in the coming week.  Next, activity pacing was explained.  That is, the 
therapist assisted each dyad member in identifying activities involving overexertion.  The 
goal was to develop an activity-rest cycle that led to increased productivity and reduced 
pain and other symptoms.  When discussing this cycle with patients who had fluctuating 
symptoms, a different activity-rest cycle was developed for periods with higher or lower 
symptom burden.  A plan for practicing each of the coping skills was then developed.  
The dyad was encouraged to use the skills as often as necessary and to meet weekly with 
each other to review their use of the skills.  Therapy termination was then discussed, 
including thoughts and feelings about the ending of the intervention sessions and referral 
to additional resources, if necessary.  
During the intervention, the therapist emphasized the importance of between-
session practice of the coping skills.  At the end of sessions 1, 2, and 3, the patient and 
caregiver were given instructions regarding home practice of the skills before the next 
session.  Moreover, they were given handouts detailing each between-session assignment 
and encouraged to track the number of times they practiced the skill on either the handout 
or a calendar in the back of their notebook.  At the beginning of sessions 2, 3, and 4, the 
patient and caregiver were asked to refer to a home practice handout and report the 
number of times they practiced certain skills.  Given that each session focused on a 
different skill, some skills (e.g., relaxation) were practiced and assessed more often than 
others.   
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Follow-up assessments were conducted via telephone with the patient and 
caregiver participating separately.  The assessments were administered at approximately 
2 and 6 weeks post-intervention by a study team member who was blind to the dyad’s 
group assignment.  The assessments took up to 30 minutes to complete and included 
symptom measures.  Participants received a $25 check for completing each assessment 
(i.e., baseline and two follow-ups).  Thus, participants who completed all assessments 
received $75 for their participation.   
 
Measures 
 Data were collected in-person during the consent process (i.e., screening 
assessment), via medical record review at baseline and both follow-ups, and via 
telephone-administered assessments at baseline and both follow-ups.  The following 
sections describe the study measures and time points for data collection.  
During the consent process, the patient completed a screening assessment in order 
to determine eligibility.  Specifically, the patient needed to pass a verbally-administered 
cognitive screener and endorse at least one moderate to severe symptom based on 
established cutpoints for self-report questionnaires.  
The Six-Item Screener (SIS) was verbally administered to patients (Callahan et 
al., 2002).  The SIS is a well-validated brief cognitive screening assessment that includes 
three questions assessing temporal orientation (i.e., day of the week, month, year) and 
three recall items.  A cutpoint of 4 or more errors (range = 0 to 6) is commonly used with 
cancer and other medical populations and identifies cognitive impairment with a 
sensitivity of 74% and specificity of 96% (Callahan et al., 2002; Kroenke, Theobald, et 
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al., 2010; Wilber, Lofgren, Mager, Blanda, & Gerson, 2005).  Thus, patients who made 4 
or more errors were considered ineligible for the study because of potential cognitive 
impairment. 
Depressive symptoms were assessed using the 2-item version of the Patient 
Health Questionnaire (PHQ-2) (Kroenke, Spitzer, & Williams, 2003).  The PHQ-2 
includes two items from the PHQ-8 that assess depressed mood and loss of interest.  The 
measure uses a 4-point rating scale, with options ranging from 0 (not at all) to 3 (nearly 
every day).  A sample item is, “Over the last two weeks, how often have you been 
bothered by little interest or pleasure in doing things?”  The PHQ-2 has demonstrated 
acceptable reliability and validity in cancer and other medical populations, with alpha 
coefficients around 0.83 (Kroenke, Theobald, et al., 2009; Löwe, Kroenke, & Gräfe, 
2005; Löwe et al., 2010).  Among medical outpatients, a PHQ-2 score of 3 or greater 
(range = 0 to 6) is commonly used to identify clinically significant depressive symptoms 
(Kroenke, Spitzer, Williams, & Löwe, 2010). 
 Anxiety symptoms were assessed using the 2-item version of the Generalized 
Anxiety Disorders scale (GAD-2) (Kroenke, Spitzer, Williams, & Löwe, 2009).  The 
GAD-2 includes two items from the GAD-7 that assess feeling anxious and not being 
able to stop or control worrying.  The measure uses a 4-point rating scale, with options 
ranging from 0 (not at all) to 3 (nearly every day).  A sample item is, “Over the last two 
weeks, how often have you been bothered by feeling nervous, anxious, or on edge?”  The 
GAD-2 has demonstrated good reliability and validity in cancer and other medical 
populations, with alpha coefficients around 0.82 (Kroenke, Spitzer, et al., 2009; Kroenke, 
Theobald, et al., 2009; Löwe et al., 2010).  Among medical outpatients, a GAD-2 score of 
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3 or greater (range = 0 to 6) is commonly used to identify clinically significant anxiety 
symptoms (Kroenke et al., 2003). 
Pain was assessed using the 3-item PEG version of the Brief Pain Inventory-Short 
Form (BPI-SF) (Krebs et al., 2009).  The PEG includes three items from the BPI-SF and 
assesses average pain severity and pain interference with enjoyment of life and general 
activity.  The measure uses an 11-point rating scale, with options ranging from 0 (no pain 
or does not interfere) to 10 (pain as bad as you can imagine or completely interferes).  A 
sample item is, “What number best describes your pain on average in the past week?”  
The PEG has shown acceptable reliability and validity in cancer and other medical 
populations, with alpha coefficients between 0.73 and 0.89 (Krebs et al., 2009; Kroenke, 
Theobald, et al., 2009).  A PEG score of 5 or greater (range = 0 to 10) is commonly used 
to identify cancer patients with moderate to severe pain (Cleeland et al., 1994; Krebs et 
al., 2009). 
 Fatigue was assessed using the 4-item Vitality subscale of the Medical Outcomes 
Short Form-36 (SF-36) (McHorney, Ware Jr, & Raczek, 1993).  Patients were asked to 
rate how they have been feeling over the past 4 weeks on a scale from 1 (all of the time) 
to 5 (none of the time).  A sample item is, “How much of the time during the past 4 weeks 
did you feel worn out?” Among cancer and other medical populations, a Vitality score of 
11 or less (range 0 to 20; standardized score < 45) is commonly used to classify fatigue as 
moderate to severe (McHorney et al., 1993; O'Connor, 2004). 
Breathlessness severity was assessed using two items from the Memorial 
Symptom Assessment Scale (MSAS) (Portenoy et al., 1994).  Patients were first asked, 
“During the past week, did you have shortness of breath?”  If they answer yes, they were 
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asked, “How severe was it usually?”  The MSAS uses a 4-point response scale, with 
options ranging from 1 (slight) to 4 (very severe).  The MSAS has been well-validated in 
cancer populations (Tittle, McMillan, & Hagan, 2003).  An MSAS shortness-of-breath 
severity score of 2 or greater (range = 0 to 4) is considered moderate to severe (Portenoy 
et al., 1994). 
Patient medical characteristics were collected at baseline via medical record 
review, including the date of the lung cancer diagnosis, disease type (i.e., small cell or 
non-small cell lung cancer) and stage, and cancer treatments received (i.e., surgery, 
chemotherapy, radiation, chemoradiation).  Cancer treatments received since the prior 
assessment were also collected from medical records at the first and second follow-ups. 
 Patient and caregiver demographics were collected at baseline via self-report, 
including gender, age, race/ethnicity, education, household income, employment status, 
relationship between the patient and caregiver, and whether the patient and caregiver live 
together.  Following, patient and caregiver smoking status were assessed using two well-
validated items from the Behavioral Risk Factor Surveillance System (BRFSS) 
questionnaire (CDC, 2007).  Specifically, dyad members were asked if they had smoked 
more than 5 packs of cigarettes in their lifetime and if they currently smoked cigarettes 
every day, some days, or not at all (CDC, 2007).  Lastly, the patient’s baseline 
performance status (i.e., ECOG score) was determined based on a validated self-report 
item (Oken et al., 1982).  The ECOG is considered the gold standard measure of 
performance status for lung cancer patients and demonstrates excellent convergent 
validity with other well-validated self-report performance status measures (Buccheri et 
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al., 1996; Oken et al., 1982).  Scores used in the current study ranged from 0 (normal 
with no limitations) to 4 (pretty much bedridden, rarely out of bed) (Oken et al., 1982).   
Patient and caregiver depressive symptoms were assessed at baseline and follow-
ups using the 8-item version of the Patient Health Questionnaire (PHQ-8) (Kroenke, 
Spitzer, et al., 2010; Löwe, Unützer, Callahan, Perkins, & Kroenke, 2004).  The PHQ-8 
uses a 4-point response scale, with options ranging from 0 (not at all) to 3 (nearly every 
day).  A sample item is, “Over the last two weeks, how often have you been bothered by 
little interest or pleasure in doing things?”  The PHQ-8 has shown excellent reliability 
and validity in cancer and general population samples, with alpha coefficients around 
0.87 and 0.89, respectively (Dwight-Johnson, Ell, & Lee, 2005; Kroenke, Spitzer, et al., 
2010; Kroenke, Theobald, et al., 2009; Rief, Nanke, Klaiberg, & Braehler, 2004).   
 Patient and caregiver anxiety symptoms were assessed at baseline and follow-ups 
using the 7-item version of the Generalized Anxiety Disorders scale (GAD-7) (Kroenke, 
Spitzer, et al., 2010; Kroenke, Spitzer, Williams, Monahan, & Löwe, 2007).  The GAD-7 
uses a 4-point response scale, with options ranging from 0 (not at all) to 3 (nearly every 
day).  A sample item is, “Over that last two weeks, how often have you been bothered by 
feeling nervous, anxious, or on edge?”  The GAD-7 has demonstrated excellent reliability 
and validity in cancer and general population samples, with alpha coefficients of 0.92 and 
0.89, respectively (Kroenke et al., 2007; Löwe et al., 2008; Spitzer, Kroenke, Williams, 
& Löwe, 2006).    
Patient pain severity was assessed at baseline and follow-ups using the BPI-SF 
(Cleeland et al., 1994).  The BPI-SF consists of four items assessing pain severity.  The 
BPI-SF uses an 11-point response scale, with options ranging from 0 (no pain) to 10 
44 
 
(pain as bad as you can imagine).  A sample item is, “What number best describes your 
pain on average in the past week?”  The BPI-SF has demonstrated good reliability and 
validity in cancer populations, with alpha coefficients around 0.95 (Tittle et al., 2003).   
 Patient distress related to breathlessness was assessed at baseline and follow-ups 
using two items from the Memorial Symptom Assessment Scale (MSAS) (Portenoy et al., 
1994).  Specifically, patients were first asked, “During the past week, did you have 
shortness of breath?”  If they answered yes, they are asked, “How much did it distress or 
bother you?”  The MSAS uses a 5-point response scale, with options ranging from 0 (not 
at all) to 4 (very much).  The MSAS has been well-validated in cancer populations (Tittle 
et al., 2003).   
 Patient fatigue interference was assessed at baseline and both follow-ups using the 
Fatigue Symptom Inventory (FSI) (Hann, Denniston, & Baker, 2000).  The FSI includes 
seven items assessing the extent to which, over the past week, fatigue interfered with 
patients’ general level of activity, activities of daily living, work ability (including 
housework and occupational work, if applicable), concentration, social relationships, life 
enjoyment, and mood.  The FSI uses an 11-point response scale, with options ranging 
from 0 (no interference) to 10 (extreme interference).  A sample item is, “Rate how 
much, in the past week, fatigue interfered with your general level of activity.”  The FSI 
has demonstrated good reliability and validity in cancer populations, with alpha 
coefficients between 0.93 and 0.95 (Hann et al., 2000; Hann et al., 1998).   
 At the beginning of sessions 2, 3, and 4, patients and caregivers were asked to 
refer to a home practice handout or calendar and report the number of times they 
practiced certain skills.  If they did not recall the referenced skill, they were referred to a 
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handout detailing the specific coping skill exercise.  The following sections describe how 
the between-session practice of the coping skills was assessed and specify when these 
measures were collected.  All of the between-session skill practice items were developed 
for this study by the PI and me.  
 At the beginning of intervention sessions 2, 3, and 4, the patient and caregiver 
were asked to report the number of times they practiced three types of relaxation 
exercises: noticing sounds and thoughts, guided imagery, and pursed lips breathing.  
Concerning noticing sounds and thoughts, they were asked, “During the past week, did 
you practice relaxation by listening to sounds around you or noticing your own thoughts 
without judging them?  How many times did you do this during the past week?”  
Concerning guided imagery, they were asked, “During the past week, did you imagine 
yourself in a peaceful place?  How many times did you do this during the past week?”  
Concerning pursed lips breathing, they were asked, “During the past week, did you use 
pursed lips breathing?  How many times did you do this during the past week?”  
Although dyads were instructed to use a CD to practice the relaxation exercises, practice 
without the CD was still scored.  
 At the beginning of sessions 3 and 4, the patient and caregiver were asked, 
“During the past week, did you replace your negative thoughts with more helpful 
thoughts? How many times did you do this during the past week?” 
 At the beginning of session 4, the patient and caregiver were asked, “During the 
past week, did you practice using the communication skills that we discussed? How many 
times did you do this during the past week?” 
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Analyses 
 All data entry, screening, and variable computation were conducted using SPSS 
statistical software version 23.0 (Armonk, NY, USA).  All data were checked for 
accuracy by two study personnel.  Following, I examined variable frequencies in order to 
identify data entry mistakes.  Measures were then computed based on their respective 
scoring instructions.  Concerning the between-session practice of the coping skills, the 
frequency of practice was summed across time points in order to assess the total amount 
of practice reported for each coping skill.    
First, preliminary analyses were conducted to identify outliers and assess 
normality.  Outliers were classified as values greater than +/- 3.0 standard deviations 
(SD) from the mean (Tabachnick & Fidell, 2007).  When outliers were identified, a 
Winsorization transformation was applied to reduce the influence of these extreme values 
(Tukey, 1962).  Multivariate outliers were then assessed by calculating Mahalanobis 
distances for all of the variables included in each model.  Mahalanobis distances (D2) 
follow a χ2 distribution, and values with p < 0.001 are considered problematic 
(Tabachnick & Fidell, 2007).  Next, the normality of the variables was assessed.  As 
recommended by Kline (2011), skewness and kurtosis indices should be less than the 
absolute values of 3.0 and 10.0, respectively.  Following, baseline descriptive statistics 
and zero-order correlations between all study variables were computed to characterize the 
sample.  Lastly, alpha coefficients were calculated to examine the internal consistency of 
the measures.   
Concerning missing data, full information maximum likelihood (FIML) data 
imputation was used in all analyses (Enders, 2001b; Kline, 2011).  FIML estimates 
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implied values for missing data based on observed data patterns.  Compared to deletion 
methods (e.g., listwise, pairwise) and single imputation, FIML produces less biased 
parameter estimates and allows for the retention of the full sample size (Enders, 2001a).   
Additionally, auxiliary variables were originally calculated to enhance the 
effectiveness of FIML data imputation.  An auxiliary variable is a variable in a statistical 
model that is included solely for improving the missing data imputation (Kline, 2011).  
Specifically, when missing data are not random (e.g., attrition due to disease 
progression), including a variable that measures the reason for the missing data can 
improve the accuracy of the parameter estimates (Collins, Schafer, & Kam, 2001).  
Auxiliary variables were computed based on the reason for attrition, including medical 
reasons (e.g., illness progression), lack of interest, and lost to follow-up.  Each participant 
received a dummy-coded score for each attrition variable.  For example, those who 
dropped out of the intervention due to illness progression were given a score of 1 on the 
medical reasons variable, whereas everyone who did not drop out due to medical reasons 
was given a score of 0.  Participants who completed both follow-up time points were 
given a score of 0 on each auxiliary variable.  I attempted running all of the models with 
every combination of auxiliary variables (e.g., 1 to 3 auxiliary variables per model).  
Unfortunately, none of the models would converge due to Phi or Psi matrices being not 
positive definite.  Thus, the final models did not include auxiliary variables.  However, I 
computed Fisher’s exact tests and independent samples t-tests to examine potential 
differences in demographic and medical characteristics and study variables at baseline 
between those who dropped out after baseline and those who completed at least one 
follow-up.  
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 The primary analyses were conducted in LISREL 8.8 (Joreskog & Sorbom, 2008) 
using autoregressive path analysis models.  Path analysis was chosen over alternative 
methods (e.g., multiple regression, repeated measures ANOVA) because it allows for 
more accurate parameter estimates by using FIML data imputation (Enders, 2001a; Kline, 
2011).  Current power analysis methods for path analysis models produce unreliable 
estimates (Kline, 2011; Lei & Wu, 2007); however, it is generally suggested that there 
should be between 5 and 20 participants per parameter (Browne & Cudeck, 1992; Kline, 
2011).  Therefore, in order to increase the subject-to-parameter ratio, each of the 
outcomes were examined in separate models (7 models overall). 
Autoregressive models can be used with longitudinal data to assess the stability of 
a construct over time (Frees, 2004; Kline, 2011).  In this study, baseline symptom scores 
were used to predict symptom scores at the first follow-up, and, in turn, symptom scores 
at the first follow-up were used to predict symptom scores at the second follow-up.  
Estimated path coefficients between the same construct (i.e., autoregressive paths) are 
referred to as stability coefficients, which reflect the consistency of the rank order of 
participants on a variable over time (Kline, 2011).  The term rank order refers to a 
participant’s relative standing on a variable in relation to other participants in the dataset 
(e.g., the patient with the most pain is ranked as number 1, the patient with the second 
highest pain is ranked as number 2, etc.).   
If a model yields large stability coefficients this suggests that the rank order of the 
symptom scores remained relatively the same from baseline to the first follow-up and 
from the first follow-up to the second follow-up (Frees, 2004; Kline, 2011).  A large 
stability coefficient could thus reflect any of the following: (1) symptoms did not change 
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over time; (2) symptoms uniformly increased or decreased over time; or (3) symptoms 
systematically changed over time with the baseline level of the symptom determining the 
amount/direction of change (i.e., the fanning effect) (Frees, 2004; Kline, 2011).  An 
example of the fanning effect can be seen in the following scenario with three groups of 
patients: (1) patients who reported high levels of pain at baseline reported even higher 
levels of pain at each follow-up; (2) patients who reported moderate levels of pain at 
baseline reported moderate levels of pain at each follow-up; and (3) patients who 
reported low levels of pain at baseline reported even lower levels of pain at each follow-
up.  Note that the rank order of the patients’ pain scores remained the same at each time 
point; thus, the stability coefficients would be large.   
In contrast, small (or zero) stability coefficients reflect a re-ordering of the rank 
order of the symptoms across time (Frees, 2004; Kline, 2011).  For example, three groups 
of patients shift in their respective rank order across time in the following scenario: (1) 
patients who reported high levels of pain at baseline reported low levels of pain at the 
first follow-up and high levels of pain at the second follow-up; (2) patients who reported 
moderate levels of pain at baseline reported high levels of pain at the first follow-up and 
low levels of pain at the second follow-up; and (3) patients who reported low levels of 
pain at baseline reported moderate levels of pain at the first follow-up and high levels of 
pain at the second follow-up. 
For Aim 1, five autoregressive models (i.e., patient pain severity, distress related 
to breathlessness, fatigue interference, depressive symptoms, and anxiety symptoms) 
were estimated to examine if increased coping skills practice (i.e., noticing sounds and 
thoughts, guided imagery, pursed lips breathing, cognitive restructuring, and assertive 
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communication) was related to reduced patient symptoms at 2 and 6 weeks post-
intervention (see Figure 1).  For Aim 2, two autoregressive models (i.e., caregiver 
depressive and anxiety symptoms) were estimated to examine if increased caregiver 
coping skills practice was related to reduced caregiver symptoms at 2 and 6 weeks post-
intervention (see Figure 2). 
My original analysis plan for Aim 2 included cross-lagged autoregressive models 
for patient and caregiver depressive and anxiety symptoms.  This approach was proposed 
due to the dyadic nature of these outcomes.  However, these models included more 
pathways than participants, making the output uninterpretable (Kline, 2011).  Thus, I 
decided to run separate models for patients and caregivers in order to increase the 
participant-to-path ratio.  The lack of dyadic analyses is noted in the Limitations and 
Future Directions section of the discussion.   
Model fit was assessed using the χ2 statistic and the root mean square error of 
approximation (RMSEA) statistic (Steiger, 1990).  A non-significant χ2 statistic indicates 
that the hypothesized model is acceptable because there is no significant difference 
between the modeled and the observed patterns of relationships (Kline, 2011).  The 
RMSEA statistic is an adjusted estimate of absolute fit accounting for the parsimony of 
the model; smaller values represent better fit with values below 0.06 indicative of good 
fit (Browne & Cudeck, 1992; Hu & Bentler, 1999).
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RESULTS 
Preliminary Analyses 
The study flow is shown in Figure 3.  To summarize, 337 potentially eligible lung 
cancer patients were approached in clinic.  Two hundred and three of the approached 
patients were excluded due to ineligibility (n = 117) or declining participation (n = 86).  
Following initial in-clinic screening, 134 patients and 128 caregivers consented to 
participate.  However, 50 participants (n = 28 patients; n = 22 caregivers) were 
withdrawn before randomization for the following reasons: lack of interest (n = 12); 
medical reasons (n = 4); lost to follow-up (n = 14); ineligibility (n = 6); or the other 
member of the dyad was withdrawn for any reason (n = 14).  Overall, 106 patients and 
106 caregivers completed baseline assessments and were randomized to TSM (n = 51 
patients; n = 51 caregivers) or attention control (n = 55 patients; n = 55 caregivers).  
The current study analyzes data from the TSM condition; thus, attrition from the 
attention control condition will not be discussed.  After being randomized to TSM, 30 
participants (n = 15 patients; n = 15 caregivers) were withdrawn before the 2 week 
follow-up.  Concerning the number of completed TSM sessions, 5 dyads completed 0 
sessions, 7 dyads completed 1 session, 1 dyad completed 3 sessions, and 32 dyads 
completed 4 sessions. 
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Reasons for withdrawal were the following: lack of interest (n = 12); medical 
reasons (n = 5); the other member of the dyad was withdrawn for any reason (n = 11); 
and death (n = 2).  Thirty-six patients and 35 caregivers completed the 2 week follow-up.  
Before the 6 week follow-up, one patient died and, thus, his or her caregiver was 
withdrawn.  One caregiver missed the 2 week follow-up time frame, but completed the 6 
week follow-up.  Thus, 35 patients and 35 caregivers completed the 6 week follow-up; 36 
patients and 36 caregivers completed at least one follow-up.  Overall there was 31.37% 
(16/51 dyads) attrition from baseline to the 6 week follow-up for both patients and 
caregivers.  
In the following sections I present data from patients and caregivers from three 
time points.  When patients and caregivers are discussed in the same sentence, I present 
patients’ statistics followed by caregivers’ statistics.  When variables are discussed across 
time, I present them chronologically (i.e., baseline, 2 weeks post-intervention, 6 weeks 
post-intervention).    
Patient and caregiver baseline characteristics are shown in Table 1.  The majority 
of patients were White (88.24%), female (54.90%), married (62.75%), and retired 
(49.02%) or unemployed (25.49%).  On average, patients were 63.47 years of age (SD = 
7.68) and had 12.92 years of education (SD = 2.22).  Most patients (64.71%) only had a 
high school degree or equivalent.  The median household income for patients was 
between $51,000 and $99,999, with 32.65% reporting income below $30,999.  Nine 
patients refused to report or did not know their household income.  Caregivers were 
primarily White (88.00%), female (72.55%), married (74.51%), and employed full-time 
(39.22%) or retired (31.37%).  On average, caregivers were 56.33 years of age (SD = 
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14.09) and had 13.94 years of education (SD = 2.85).  Around 45.10% of caregivers only 
had a high school degree or equivalent.  The median household income for caregivers 
was also between $51,000 and $99,999, with 25.49% reporting income below $30,999.  
Six caregivers refused to report or did not know their household income.  The majority of 
caregivers were patients’ spouses or partners (62.75%); however, some caregivers were 
patients’ sons or daughters (17.65%) or other family members or friends (19.61%). 
Patient medical information is shown in Table 2.  Patients were enrolled from the 
Indiana University Simon Cancer Center (76.47%), the Roudebush VA Medical Center 
(19.61%), and the Eskenazi Hospital in Indianapolis (3.92%).  Forty-four patients had 
non-small cell lung cancer (NSCLC; 86.27%) and seven had small-cell lung cancer 
(SCLC; 13.73%).  Most patients (62.75%) had advanced-stage disease (i.e., stage III or 
IV NSCLC or extensive SCLC) and the median time since diagnosis was 0.57 years (SD 
= 2.12).  The majority of patients had received chemotherapy (52.94%), followed by 
surgery (47.06%), radiation (25.49%), and concurrent chemoradiation (23.53%).  The 
mean self-reported ECOG score was 1.43 (SD = 0.92), suggesting that the average patient 
was able to be active but did not feel well (Oken et al., 1982).  
Descriptive statistics regarding intervention-period coping skills practice for 
patients and caregivers are presented in Table 3.  From sessions 2 to 4, noticing sounds 
and thoughts was practiced an average of 12.98 (SD = 9.73) and 11.74 (SD = 11.83) 
times.  Similarly, from sessions 2 to 4, guided imagery was practiced an average of 11.59 
(SD = 9.39) and 8.33 (SD = 7.48) times.  Pursed lips breathing was practiced more 
frequently than the other coping skills from sessions 2 to 4, with an average of 29.60 (SD 
= 32.56) and 15.05 (SD = 17.22) times.  From sessions 3 to 4, cognitive restructuring was 
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practiced an average of 9.87 (SD = 10.64) and 10.82 (SD = 12.07) times.  Lastly, from 
session 4, assertive communication was practiced an average of 4.83 (SD = 4.50) and 
4.26 (SD = 3.80) times.  
Descriptive statistics on patient and caregiver depressive and anxiety symptoms 
are presented in Table 4.  The PHQ-8 demonstrated acceptable internal consistency 
across time points for patients (α coefficients = 0.78, 0.70, and 0.85) and caregivers (α 
coefficients = 0.87, 0.84, and 0.86).  The GAD-7 also had good internal consistency 
across time points for patients (α coefficients = 0.88, 0.83, and 0.86) and caregivers (α 
coefficients = 0.88, 0.83, and 0.87).   
On average, patients reported mild depressive symptoms (PHQ-8 scores from 5 to 
9; Kroenke, Spitzer, Williams, & Löwe, 2010) across time points, with mean PHQ-8 
scores of 7.31 (SD = 4.77), 6.36 (SD = 3.75), and 6.71 (SD = 4.77).  Caregivers also 
reported mild depressive symptoms on average across time points, with mean PHQ-8 
scores of 5.67 (SD = 5.59), 5.09 (SD = 4.88), and 4.83 (SD = 4.77).  Patients reported 
mild anxiety (GAD-7 scores from 5 to 9; Kroenke, Spitzer, Williams, & Löwe, 2010) at 
baseline, with mean GAD-7 scores of 5.12 (SD = 4.89).  However, at 2 and 6 weeks post-
intervention, patients reported minimal anxiety (GAD-7 scores from 0 to 4; Kroenke, 
Spitzer, Williams, & Löwe, 2010), with mean scores of 3.72 (SD = 3.45) and 4.06 (SD = 
3.82).  Caregivers reported mild anxiety across time points, with mean GAD-7 scores of 
6.10 (SD = 5.19), 5.06 (SD = 4.28), and 5.00 (SD = 4.77). 
Patient symptoms across time are presented in Table 5.  The symptom measures 
with multiple items had excellent internal consistency at all time points, including pain 
severity (α coefficients = 0.94, 0.92, and 0.94) and fatigue interference (α coefficients = 
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0.94, 0.93, and 0.94).  On average, pain severity was consistent from baseline to 2 and 6 
weeks post-intervention, with mean scores of 2.61 (SD = 2.47), 2.24 (SD = 2.16), and 
2.64 (SD = 2.49).  Patients were, on average, below clinical levels of pain (BPI-SF score 
of 5 or greater; Cleeland et al., 1994) at all time points.  Distress related to breathlessness 
was also consistent across time points on average, with mean scores of 1.22 (SD = 1.12), 
1.33 (SD = 1.35), and 1.20 (SD = 1.23).  A score of 1 on the MSAS suggests patients 
were a little distressed or bothered by breathlessness (Portenoy et al., 1994).  Lastly, 
fatigue interference was also consistent across time points, with mean scores of 3.20 (SD 
= 2.46), 2.53 (SD = 2.04), and 2.87 (SD = 2.44).  A fatigue interference score greater than 
5 on the FSI is considered clinically meaningful fatigue (Hann et al., 2000).   
Preliminary analyses were conducted to identify outliers and assess normality.  
Univariate outliers were classified as values greater than +/- 3.0 standard deviations from 
the mean (Tabachnick & Fidell, 2007).  Five outliers were identified in the coping skills 
practice variables (see Table 6).  A Winsorization transformation was thus applied to 
reduce the influence of these extreme values (Tukey, 1962).  Based on Mahalanobis 
distances, there were no multivariate outliers for any combination of the variables 
included in each model (all D2 ps > 0.001).  Variable normality was also assessed.  All 
skewness and kurtosis indices were less than the absolute values of 3.0 and 10.0, 
respectively (see Tables 3, 4, and 5).  Lastly, concerning power, all of the models had a 
participant-to-parameter ratio of 4.25 (51 participants to 12 pathways), which is below 
the recommended minimum of 5 participants per path (Browne & Cudeck, 1992; Kline, 
2011).   
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Independent samples t-tests and Fisher’s exact tests were conducted to examine 
potential baseline differences between those who dropped out after baseline and those 
who completed at least one follow-up (see Tables 7 and 8).  There were only a few 
significant between-group differences.  Specifically, caregivers who were withdrawn (n = 
15) were more likely to have lower income (p < 0.01) and live with the patient (p = 0.04), 
compared to caregivers who completed at least one follow-up (n = 36).  All other baseline 
comparisons were non-significant, including symptom measures (see Table 8).  With 
these few exceptions, there were no other identifiable patterns of missingness.  Thus, full 
information maximum likelihood (FIML) data imputation was used in all path analyses 
(Enders, 2001a; Kline, 2011).  It is important to note, however, that many of the attrition 
analyses were underpowered due to small sample sizes and unequal variances within 
some of the groups.  Thus, the results should be interpreted cautiously.   
Pearson correlations were computed to characterize the relationships between 
study variables (see Tables 9 to 18).  The following sections summarize the results of 
these analyses.  
Concerning patients’ coping skills practice (see Table 9), most showed moderate 
to strong positive associations with one another (rs = 0.34 to 0.67, p < 0.05).  The most 
notable exception was assertive communication, which was positively associated with 
noticing sounds and thoughts (r = 0.51, p < 0.01), but was not significantly related to any 
of the other coping skills (ps > 0.05).  Additionally, cognitive restructuring was not 
significantly related to guided imagery, though there was a positive trend (r = 0.32, p = 
0.05).  Most of the caregivers’ coping skills practices showed moderate to strong positive 
associations with one another (rs = 0.33 to 0.73, ps < 0.05).  There were only two 
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exceptions.  Similar to patients, caregivers’ guided imagery practice was not significantly 
related to cognitive restructuring or assertive communication practice (rs = 0.05 and 0.07, 
ps > 0.05). 
Patients’ and caregivers’ coping skills practices tended to be positively correlated, 
with moderate to strong strength (rs = 0.33 to 0.77, ps < 0.05).  There were a few 
exceptions.  Specifically, patients’ guided imagery practice was not significantly related 
to caregivers’ pursed lips breathing or assertive communication; however, the effect sizes 
were moderate and fell just short of significance (rs = 0.31 to 0.30, ps = 0.05 and 0.06).  
In addition, patients’ pursed lips breathing was not significantly related to caregivers’ 
assertive communication (r = -0.03, p > 0.05).  Lastly, caregivers’ guided imagery 
practice was not significantly related to patients’ pursed lips breathing, cognitive 
restructuring, or assertive communication (rs = 0.22, 0.01, -0.02, ps > 0.05, respectively).   
Concerning correlations between depressive and anxiety symptoms (see Table 
10), I present the following: (1) patients’ and caregivers’ depressive and anxiety 
symptoms separately; (2) intercorrelations between patients’ and caregivers’ depressive 
symptoms; (3) intercorrelations between patients’ and caregivers’ anxiety symptoms; and 
(4) intercorrelations between patients’ and caregivers’ depressive and anxiety symptoms.  
First, patients’ depressive symptoms tended to be positively correlated over time 
and positively correlated with their anxiety symptoms (rs = 0.39 to 0.79, ps < 0.05); there 
were also six positive correlations that were small to moderate in effect size but non-
significant (rs = 0.28 to 0.31, ps = 0.06 to 0.19).  Patients’ anxiety symptoms at baseline 
were not significantly related to their depressive symptoms at 2 weeks post-intervention 
(r = 0.05, p > 0.05).  Similarly, patients’ anxiety symptoms at 2 weeks post-intervention 
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were not significantly related to their depressive symptoms at 6 weeks post-intervention 
(r = -0.02, p > 0.05).  In contrast to patients, caregivers’ depressive and anxiety 
symptoms showed strong positive correlations across all time points (rs = 0.59 to 0.87, ps 
< 0.01). 
Second, patients’ and caregivers’ depressive symptoms were positively correlated 
at baseline (r = 0.32, p < 0.05); however, these associations were not significant at the 
two follow-ups.  There were also a few significant cross-lagged effects.  Specifically, 
caregivers’ depressive symptoms at baseline were positively correlated with patients’ 
depressive symptoms at 2 weeks post-intervention (r = 0.35, p < 0.05); patients’ 
depressive symptoms at 2 weeks post-intervention were positively correlated with 
caregivers’ depressive symptoms at 6 weeks post-intervention (r = 0.34, p < 0.05). 
Third, patients’ and caregivers’ anxiety symptoms were positively correlated at 
the same time points (rs = 0.37 to 0.40, ps < 0.05), and there were some significant cross-
lagged effects.  Specifically, caregivers’ anxiety symptoms at baseline were positively 
associated with patients’ anxiety symptoms at 2 weeks post-intervention (r = 0.51, p < 
0.01); similarly, patients’ anxiety symptoms at baseline were positively associated with 
caregivers’ anxiety symptoms at 6 weeks post-intervention (r = 0.38, p < 0.05).  Patients’ 
anxiety symptoms at 2 weeks post-intervention were also positively associated with 
caregivers’ anxiety symptoms at 6 weeks post-intervention (r = 0.53, p < 0.01).   
Fourth, patients’ and caregivers’ depressive and anxiety symptoms were 
positively correlated at the same time points (rs = 0.34 to 0.40, ps < 0.05), and there were 
some significant cross-lagged effects.  Specifically, caregivers’ depressive symptoms at 
baseline were positively associated with patients’ anxiety symptoms at 2 weeks post-
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intervention (r = 0.47, p < 0.01); similarly, caregivers’ anxiety symptoms at baseline 
were positively associated with patients’ depressive symptoms at 2 weeks post-
intervention (r = 0.35, p < 0.05).  Patients’ anxiety symptoms at baseline were positively 
associated with caregivers’ depressive symptoms at 6 weeks post-intervention (r = 0.44, p 
< 0.01).  Lastly, patients’ depressive symptoms at 2 weeks post-intervention were 
positively associated with caregivers’ anxiety symptoms at 6 weeks post-intervention (r = 
0.37, p < 0.01); similarly, patients’ anxiety symptoms at 2 weeks post-intervention were 
positively associated with caregivers’ depressive symptoms at 6 weeks post-intervention 
(r = 0.52, p < 0.01). 
The patients’ symptoms showed moderate to strong positive correlations from 
baseline to the two follow-ups, including pain severity (rs = 0.78 to 0.81, ps < 0.01), 
distress related to breathlessness (rs = 0.45 to 0.72, ps < 0.01), and fatigue interference 
(rs = 0.50 to 0.65, ps < 0.05).  Concerning correlations between symptoms, pain severity 
was positively associated with fatigue interference across most time points (rs = 0.38 to 
0.61, ps < 0.05).  The only exceptions were fatigue interference at baseline and 2 weeks 
post-intervention and pain severity at 6 weeks post-intervention, both of which were 
positive moderate effects that fell short of significance (rs = 0.32 and 0.33, ps = 0.06).  
Distress related to breathlessness at baseline was positively associated with fatigue 
interference at baseline (r = 0.35, p < 0.05); similarly, distress related to breathlessness at 
2 weeks post-intervention was positively associated with fatigue interference at 2 weeks 
post-intervention (r = 0.35, p < 0.05).  The remaining associations between distress 
related to breathlessness and the other symptoms tended to be positive, small to moderate 
effect sizes, and non-significant (rs = 0.17 to 0.33, ps = 0.05 to 0.34).   
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Correlations were computed for each of the variables included in the seven path 
models (see Tables 12 to 18).  Significant correlations in the predicted directions provide 
preliminary support for my hypotheses.  
Concerning patient coping skills and symptoms (see Tables 12 to 16), there was 
little preliminary support for my hypotheses.  None of the coping skills demonstrated 
significant negative associations with symptoms at 2 or 6 weeks post-intervention.  There 
were, however, a few non-significant small effects in the predicted directions.  
Specifically, there were small negative associations between assertive communication 
and pain severity (r = -0.23, p = 0.20), depressive symptoms (r = -0.21, p = 0.23), and 
anxiety symptoms (r = -0.20, p = 0.25) at 6 weeks post-intervention.  Thus, there was 
some tentative support for a few pathways posited in Hypotheses 1.2, 1.4, and 1.5.   
Unfortunately, some of the patients’ coping skills practice demonstrated effects 
opposite of those predicted.  Contrary to Hypothesis 1.2, cognitive restructuring had a 
significant positive association with distress related to breathlessness at 6 weeks post-
intervention (r = 0.45, p < 0.01).  There were other non-significant trends in the opposite 
direction of my hypotheses, such as the following: (1) cognitive restructuring and distress 
related to breathlessness at 2 weeks post-intervention (r = 0.28, p = 0.10); (2) noticing 
sounds and thoughts and distress related to breathlessness at 6 weeks post-intervention (r 
= 0.32, p = 0.06); (3) guided imagery and distress related to breathlessness at 6 weeks 
post-intervention (r = 0.27, p = 0.12); (4) cognitive restructuring and depressive 
symptoms at 6 weeks post-intervention (r = 0.21, p = 0.23); and (5) cognitive 
restructuring and anxiety symptoms at 6 weeks post-intervention (r = 0.30, p = 0.08).   
61 
 
Concerning caregivers’ coping skills and symptoms (see Tables 17 and 18), there 
was no preliminary support for Hypotheses 2.1 or 2.2.  None of the coping skills 
demonstrated significant negative associations with symptoms at 2 or 6 weeks post-
intervention.  As with patients, there were some non-significant trends in the opposite 
direction of my hypotheses.  Specifically, there were small positive trends between 
noticing thoughts and sounds, cognitive restructuring, and assertive communication and 
depressive symptoms at 2 weeks post-intervention (rs = 0.23 to 0.26, ps = 0.14 to 0.18).  
There were also small positive trends between noticing thoughts and sounds and guided 
imagery and anxiety symptoms at 2 weeks post-intervention (rs = 0.21 and 0.20, ps = 
0.24 and 0.26), as well as assertive communication and anxiety symptoms at 6 weeks 
post-intervention (r = 0.20, p = 0.25). 
 
Primary Analyses 
To test my study hypotheses I ran seven measured-variable path models, with one 
symptom per model (see Figures 1 and 2 for conceptual models, Figures 4 to 10 for path 
models, and Appendix B for LISREL syntax).  Each model tested relationships between 
intervention-period coping skills practice and symptom change at 2 and 6 weeks post-
intervention.  Autoregressive paths were included in each model to control for symptom 
levels at baseline and 2 weeks post-intervention.  Coping skills were allowed to covary in 
each model.  Overall, the models tended to fit the data adequately; however, only some of 
the hypothesized pathways were supported.  The following sections describe the findings 
of each model.      
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Model 1 provided some support for Hypothesis 1.1, which posited that patients’ 
increased coping skills practice would be associated with reduced pain severity at 2 and 6 
weeks post-intervention (see Figure 4).  The model fit the data well, χ2 (12, N = 51) = 
7.78, p = 0.80, RMSEA = 0.00, 90% confidence interval (0.00, 0.10).  The two stability 
coefficients were large and significant (β = 0.77 and β = 0.71, p < 0.05), suggesting the 
rank order of patients’ pain severity tended to be stable over time.  Contrary to 
Hypothesis 1.1, most of the coping skills were not significantly associated with pain 
severity at 2 or 6 weeks post-intervention.  The only exception was assertive 
communication.  Specifically, in support of Hypothesis 1.1, greater assertive 
communication practice was associated with reduced pain severity at 6 weeks post-
intervention (β = -0.28, p < 0.05).  In total, the model accounted for 69% and 65% of the 
variance in pain severity at 2 and 6 weeks post-intervention. 
Model 2 did not provide support for Hypothesis 1.2, which posited that patients’ 
increased coping skills practice would be associated with reduced distress associated with 
breathlessness at 2 and 6 weeks post-intervention (see Figure 5).  The model fit the data 
well, χ2 (12, N = 51) = 0.43, p = 0.99, RMSEA = 0.00, 90% confidence interval (0.00, 
0.00).  The two stability coefficients were large and significant (β = 0.72 and β = 0.50, p 
< 0.05), suggesting the rank order of patients’ distress related to breathlessness tended to 
be stable over time.  Contrary to Hypothesis 1.2, none of the coping skills were 
significantly associated with distress related to breathlessness in the hypothesized 
direction.  Specifically, greater cognitive restructuring practice was associated with 
greater distress related to breathlessness at 6 weeks post-intervention (β = 0.31, p < 0.05).  
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In total, the model accounted for 59% and 51% of the variance in distress related to 
breathlessness at 2 and 6 weeks post-intervention. 
Model 3 provided mixed support for Hypothesis 1.3, which posited that patients’ 
increased coping skills practice would be associated with reduced fatigue interference at 
2 and 6 weeks post-intervention (see Figure 6).  The model fit the data well, χ2 (12, N = 
51) = 2.76, p = 0.99, RMSEA = 0.00, 90% confidence interval (0.00, 0.00).  The two 
stability coefficients were large and significant (β = 0.71 and β = 0.51, p < 0.05), 
suggesting the rank order of patients’ fatigue interference tended to be stable over time.  
Contrary to Hypothesis 1.3, greater practice of noticing sounds and thoughts was 
associated with greater fatigue interference at 6 weeks post-intervention (β = 0.80, p < 
0.05).  However, in support of Hypothesis 1.3, greater practice of guided imagery and 
assertive communication were associated with reduced fatigue interference at 6 weeks 
post-intervention (β = -0.55 and β = -0.36, p < 0.05).  None of the other pathways were 
significant.  In total, the model accounted for 50% and 44% of the variance in fatigue 
interference at 2 and 6 weeks post-intervention.   
Model 4 provided mixed support for Hypothesis 1.4, which posited that patients’ 
increased coping skills practice would be associated with reduced depressive symptoms 
at 2 and 6 weeks post-intervention (see Figure 7).  The model fit the data well, χ2 (12, N = 
51) = 5.30, p = 0.95, RMSEA = 0.00, 90% confidence interval (0.00, 0.02).  The two 
stability coefficients were moderate and significant (β = 0.36 and β = 0.40, p < 0.05), 
suggesting the rank order of patients’ depressive symptoms were somewhat stable with 
some fluctuations over time.  Contrary to Hypothesis 1.4, greater practice of cognitive 
restructuring was associated with greater depressive symptoms at 6 weeks post-
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intervention (β = 0.35, p < 0.05).  In support of Hypothesis 1.4, greater practice of 
assertive communication was associated with reduced depressive symptoms at 6 weeks 
post-intervention (β = -0.37, p < 0.05).  None of the other pathways were significant.  In 
total, the model accounted for 17% and 40% of the variance in depressive symptoms at 2 
and 6 weeks post-intervention. 
Model 5 provided mixed support for Hypothesis 1.5, which posited that patients’ 
increased coping skills practice would be associated with reduced anxiety symptoms at 2 
and 6 weeks post-intervention (see Figure 8).  The model fit the data well, χ2 (12, N = 51) 
= 5.42, p = 0.94, RMSEA = 0.00, 90% confidence interval (0.00, 0.03).  The first stability 
coefficient was moderate and significant (β = 0.41, p < 0.05); however, the second 
stability coefficient was smaller and non-significant (β = 0.28, p > 0.05).  This suggests 
the rank order of patients’ anxiety showed moderate change from baseline to 2 weeks 
post-intervention.  From 2 to 6 weeks post-intervention, however, the rank order of 
patients’ anxiety changed substantially.  Contrary to Hypothesis 1.5, greater practice of 
noticing sounds and thoughts as well as cognitive restructuring were associated with 
greater anxiety symptoms at 6 weeks post-intervention (β = 0.59 and β = 0.37, p < 0.05).  
However, in support of Hypothesis 1.5, greater practice of guided imagery and assertive 
communication were associated with reduced anxiety symptoms at 6 weeks post-
intervention (β = -0.48 and β = -0.45, p < 0.05).  None of the other pathways were 
significant.  In total, the model accounted for 19% and 38% of the variance in anxiety 
symptoms at 2 and 6 weeks post-intervention. 
Model 6 did not provide support for Hypothesis 2.1, which posited that 
caregivers’ increased coping skills practice would be associated with reduced depressive 
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symptoms at 2 and 6 weeks post-intervention (see Figure 9).  The model showed 
adequate fit to the data, χ2 (12, N = 51) = 8.88, p = 0.71, RMSEA = 0.00, 90% confidence 
interval (0.00, 0.12).  Of note, the 90% confidence interval for the RMSEA did include 
0.12, which is slightly above the recommended cut-off of 0.10 (Kline, 2011).  The two 
stability coefficients were large and significant (β = 0.77 and β = 0.65, p < 0.05), 
suggesting the rank order of caregivers’ depressive symptoms tended to be stable over 
time.  Contrary to Hypothesis 2.1, none of the coping skills were significantly associated 
with caregivers’ depressive symptoms.  In total, the model accounted for 66% and 43% 
of the variance in caregivers’ depressive symptoms at 2 and 6 weeks post-intervention. 
Model 7 did not provide support for Hypothesis 2.2, which posited that 
caregivers’ increased coping skills practice would be associated with reduced anxiety 
symptoms at 2 and 6 weeks post-intervention (see Figure 10).  The model showed 
adequate fit to the data, χ2 (12, N = 51) = 12.40, p = 0.41, RMSEA = 0.03, 90% 
confidence interval (0.00, 0.16).  However, the 90% confidence interval for the RMSEA 
included 0.16, which is higher than  recommendations (Kline, 2011).  The two stability 
coefficients were large and significant (β = 0.64 and β = 0.74, p < 0.05), suggesting the 
rank order of caregivers’ anxiety symptoms tended to be stable over time.  Contrary to 
Hypothesis 2.2, none of the coping skills were significantly associated with anxiety 
symptoms in the hypothesized direction.  Indeed, greater guided imagery practice was 
associated with greater anxiety symptoms at 2 weeks post-intervention (β = 0.31, p < 
0.05).  In total, the model accounted for 54% and 52% of the variance in caregivers’ 
anxiety symptoms at 2 and 6 weeks post-intervention. 
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Conclusions from Primary Analyses 
To summarize the findings, all models showed at least adequate fit to the data; 
however, only some of the hypothesized pathways were supported.  There were no 
significant associations in the predicted directions between coping skills practice and 
patients’ physical and psychological symptoms at 2 weeks post-intervention.  For patients 
at 6 weeks post-intervention, more assertive communication practice was associated with 
less pain severity, fatigue interference, and depressive and anxiety symptoms; 
additionally, more guided imagery practice was associated with less fatigue interference 
and anxiety.  Contrary to my hypotheses, however, more cognitive restructuring practice 
was associated with more distress related to breathlessness and depressive and anxiety 
symptoms.  Similarly, more practice of noticing sounds and thoughts was associated with 
more fatigue interference and anxiety.  Concerning caregivers, there was no support for 
my hypotheses.  The only significant association was in the opposite direction of my 
hypothesis and suggested that more guided imagery practice was associated with more 
anxiety at 2 weeks post-intervention.  All other pathways at 2 and 6 weeks post-
intervention were not significant for patients or caregivers.
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DISCUSSION 
 The purpose of this study was to identify effective components of a psychosocial 
intervention for lung cancer patients and their family caregivers.  An essential step in 
developing more cost-effective and efficacious interventions is determining the degree to 
which certain intervention components lead to improved health outcomes (Czaja et al., 
2003; Kazdin, 2007).  This study examined associations between specific intervention 
components (i.e., coping skills practice) and symptom change in a telephone symptom 
management (TSM) intervention delivered concurrently to symptomatic lung cancer 
patients and their family caregivers.  My hypotheses were based on social cognitive 
theory (SCT; Bandura, 1986, 2004), cognitive-behavioral therapy frameworks (CBT; 
Beck & Weishaar, 1989; Dobson, 2009), and previous research suggesting that greater 
practice of coping skills may reduce specific symptoms in cancer populations (Andersen 
et al., 2007; Chan et al., 2012; Cohen & Fried, 2007).  The results provided mixed 
support for my hypotheses.  Specifically, two coping skills (i.e., assertive communication 
and guided imagery) showed promising effects for certain patient symptoms; however, 
the other coping skills (i.e., noticing sounds and thoughts, pursed lips breathing, and 
cognitive restructuring) showed no effects or effects opposite of those hypothesized for 
both patient and caregiver symptoms.  In the following sections I discuss these findings 
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and their implications for theory, research, and clinical practice.  Lastly, I present study 
strengths, limitations, and future directions.  
 
Coping Skills Practice Associated with Lower Symptoms 
 There are multiple interpretations of findings consistent with my hypotheses that 
frame the discussion.  Theory (Bandura, 1986, 2004; Beck & Weishaar, 1989; Dobson, 
2009) and previous research (Andersen et al., 2007; Chan et al., 2012; Cohen & Fried, 
2007) suggest causal relationships between increased coping skills practice and reduced 
symptoms in cancer patients and their family caregivers.  In the current study, 
autoregressive analyses provide compelling support for causal statements by allowing 
coping skills to predict changes in symptoms over time (Frees, 2004; Kline, 2011).  
However, only experimental design can determine cause and effect (Tabachnick & Fidell, 
2007).  Thus, a negative association between practice of a coping skill and symptom 
change can be interpreted in the following ways: (1) increased practice of the coping skill 
decreased the symptom either directly or indirectly; (2) increased practice of the coping 
skill was reciprocally related to decreases in the symptom over time; or (3) a third 
variable (e.g., self-efficacy) caused an increase in the practice of the coping skill and a 
decrease in the symptom, or vice versa (Tabachnick & Fidell, 2007).  There are also 
methodological limitations of this study (e.g., statistical power) that likely influenced the 
results and warrant consideration (see Limitations and Future Directions).  In the next 
two sections I discuss the findings that were consistent with my hypotheses.  
 Assertive communication was the coping skill practice most consistently 
associated with reduced patient symptoms.  Patients who more frequently practiced 
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assertive communication during the intervention tended to report less pain severity, 
fatigue interference, depressive symptoms, and anxiety at 6 weeks post-intervention.  To 
interpret these findings it is important to understand how assertive communication skills 
were taught in TSM.  Specifically, assertive communication was presented to dyads as a 
means of communicating in a direct, honest, and respectful manner.  Dyads were 
encouraged to use assertive communication to effectively elicit social support, 
communicate thoughts and feelings about cancer, and obtain medical attention for 
symptoms (Badr & Taylor, 2006; Keefe et al., 2005).  Thus, all three of these areas may 
be mechanisms through which assertive communication decreased patient symptoms.  
First, prior research has shown that eliciting social support can reduce cancer 
patients’ pain severity, fatigue interference, and psychological distress (Badr & Taylor, 
2006; Berger et al., 2012; Keefe et al., 2005; Porter et al., 2011).  Such findings are not 
surprising, as each of these symptoms can be exacerbated when a cancer patient does not 
receive sufficient practical assistance (Walker, Zona, & Fisher, 2006; Whelan et al., 
1997).  For example, consider a lung cancer patient who needs help with household 
chores that increase his or her pain, lead to greater fatigue, and increase anxiety and 
depressive symptoms.  Learning to assertively request assistance could help the patient 
receive practical support and, thus, reduce these symptoms.     
Second, assertively communicating thoughts and feelings about cancer may 
reduce symptoms for some patients (Badr & Taylor, 2006; Berger et al., 2012; Keefe et 
al., 2010; Porter et al., 2009).  Theory and previous research suggests emotional and 
cognitive processing of cancer-related issues can be hampered by negative social 
interactions, leading to poorer adjustment and exacerbated symptoms (Adams, Winger, & 
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Mosher, 2015; Badr & Taylor, 2006; Lepore, 2001; Moyer et al., 2012).  There is also 
some evidence that the health effects of emotional disclosure for cancer patients may be 
mediated through physiological mechanisms, such as decreased heart rate (Low, Stanton, 
& Danoff-Burg, 2006).  Improving cancer patients’ communication skills may enhance 
emotional disclosure and reduce negative social interactions, thus improving symptoms 
(Adams et al., 2015; Low et al., 2006; Manne et al., 2007).  To date, a few studies have 
shown beneficial effects of interventions focused on improving patients’ ability to 
communicate their thoughts and feelings about cancer (Manne et al., 2007; Porter et al., 
2009).  However, more studies with cancer patients are needed to determine which 
aspects of communication are most amenable to intervention.  
Third, obtaining medical attention for symptoms is another explanation for 
beneficial effects of assertive communication on patient symptoms (Andersen, Golden-
Kreutz, Emery, & Thiel, 2009; Andersen et al., 1994; Keefe et al., 2005).  It is logical to 
assume that patients will receive better symptom management if they can effectively 
communicate with their treatment team (Andersen et al., 2009).  However, previous 
studies show that many patients find it difficult to be assertive during encounters with 
their providers (Fried, Bradley, O'Leary, & Byers, 2005; Kimberlin, Brushwood, Allen, 
Radson, & Wilson, 2004).  For example, in a qualitative study with cancer patients and 
their caregivers, some patients reported feeling tension during oncology appointments 
because they did not know how to communicate their desire for better symptom 
management (Kimberlin et al., 2004).  The current findings are also consistent with a 
previous study that explored intervention component effectiveness in a 12-month 
psychosocial RCT for breast cancer patients (Andersen et al., 2007).  Specifically, 
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Andersen et al. (2007) found an association between greater practice of assertive 
communication with treatment providers and global symptom reduction.  The assertive 
communication effects were strongest following chemotherapy treatment when 
symptoms are typically most severe (Andersen et al., 2007).  Thus, the current study 
provides further evidence that brief assertive communication training may be an effective 
way to enhance symptom management for cancer patients.  
It is worth noting that assertive communication was only significantly associated 
with certain patient symptoms at 6 weeks post-intervention.  There are multiple ways to 
interpret these findings.  One possibility is that patients may have experienced a time lag 
between their assertive conversations and the receipt of support or treatment changes to 
better manage their symptoms.  For example, a patient may discuss his or her pain 
management with the treatment team.  Such conversations may lead to therapeutic 
interventions (e.g., palliative radiation) that take time to reduce the patient’s pain.  
Additionally, assertive communication and symptom change may have been reciprocally 
related over time.  Patients may have started by practicing the skill in minor ways and 
then progressed to larger requests over time.  Consistent with SCT (Bandura, 1986, 
2004), as the patient sees positive effects from his or her assertive communication this 
likely reinforces the skill which, in turn, leads to more use and better results.   
Guided imagery was the second coping skill associated with reductions in some 
patient symptoms.  Specifically, patients who practiced more guided imagery during the 
intervention tended to report less fatigue interference and anxiety at 6 weeks post-
intervention.  These findings are consistent with multiple RCTs and a previous 
intervention component analysis with cancer patients (Cohen & Fried, 2007; Kangas et 
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al., 2008; Porter et al., 2011; Roffe, Schmidt, & Ernst, 2005).  Specifically, Cohen and 
Fried (2007) explored between-session practice of coping skills in relation to 
psychological distress (e.g., depressive and anxiety symptoms) and fatigue after two 
group-based interventions for 114 early-stage breast cancer patients.  One of the 
interventions focused on CBT-based skills, such as cognitive restructuring and problem-
solving.  The other intervention focused entirely on relaxation, with particular emphasis 
on guided imagery.  These two interventions were compared to a wait-list control group.  
Relative to the control group, both interventions produced greater reductions in 
psychological distress; however, the relaxation group also reduced fatigue whereas the 
CBT group did not.  Additionally, patients in the relaxation group practiced coping skills 
more often than those in the CBT group.  Increased coping skills practice in both groups 
was significantly related to post-intervention reductions in psychological distress and 
fatigue.  Unfortunately, it was not reported whether the associations between coping 
skills practice and symptom reduction were significantly different between the two 
intervention groups.  The current results extend these findings and suggest practicing 
guided imagery may be particularly helpful for anxiety and fatigue interference.  It should 
be noted, however, that major differences in study design (e.g., group-based intervention) 
and cancer population (e.g., early-stage breast cancer) limit these conclusions.    
Guided imagery is theorized to reduce fatigue interference and anxiety through 
multiple mechanisms, including reduced emotional arousal and distraction (Andersen et 
al., 1994; Benson & Klipper, 1992; Dobson, 2009).  Fatigue is often reported as a 
debilitating symptom that interferes with many aspects of lung cancer patients’ lives 
(Hickok et al., 1996; Hopwood & Stephens, 1995; Hürny et al., 1993; Okuyama et al., 
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2001; Tanaka et al., 2002b); additionally, focusing attention on the fatigue is posited to 
make it interfere even more with the patient’s functioning (Berger et al., 2012).  Guided 
imagery, however, can serve as a distraction from this symptom, thus allowing the patient 
to focus attention on something other than his or her fatigue (Escalante & Manzullo, 
2009; Kangas et al., 2008).  As the patient gains a greater sense of control over the 
fatigue, self-efficacy for managing this symptom may increase as well (Bandura, 1986, 
2004).  Over time, guided imagery may be an effective means of lowering emotional 
arousal related to fatigue.  Lowered emotional arousal may also help some patients 
initiate sleep, thereby reducing fatigue. 
Similarly, guided imagery practice may reduce anxiety in lung cancer patients in 
multiple ways.  Guided imagery is a highly structured coping skill, which is one reason it 
may be helpful for cancer patients with anxiety (Roffe et al., 2005; Sloman, 2002; Tusek, 
Church, Strong, Grass, & Fazio, 1997).  When a patient’s thoughts are consumed with 
rumination and worry, guided imagery practice may reduce emotional arousal and induce 
relaxation thus providing a reprieve from the anxiety (Andersen et al., 1994; Benson & 
Klipper, 1992; Dobson, 2009).  Additionally, guided imagery can function as an 
immediate distraction from anxious thoughts (Roffe et al., 2005).  This is particularly 
helpful when the content of the anxious thoughts is realistic and time bound, such as 
worrying about an upcoming oncology visit.  The patient may have many realistic fears 
about the visit (e.g., disease progression); thus, problem solving or cognitive restructuring 
is not an appropriate coping skill to utilize (Greer, Park, Prigerson, & Safren, 2010).  As 
with fatigue, gaining a respite from the anxiety will likely increase the patient’s sense of 
control and self-efficacy for managing this symptom (Bandura, 1986, 2004). 
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Guided imagery was only related to reduced fatigue interference and anxiety at 6 
weeks post-intervention.  In contrast to assertive communication, explanations for this 
finding are not as clear.  One possibility is that some patients may have become 
increasingly skilled with guided imagery and, thus, experienced larger reductions in 
symptoms over time.  Additionally, the stability coefficients for fatigue interference and 
anxiety suggest there was substantial re-ordering of patients on these symptoms between 
2 and 6 weeks post-intervention; thus, there was more variance to predict at 6 weeks post-
intervention than at 2 weeks post-intervention.  Therefore, significant effects of guided 
imagery practice may not have been detectable at 2 weeks post-intervention.   
 
Coping Skills Practice Associated with Greater Symptoms 
 For some of the coping skills, there were surprising associations opposite of those 
predicted; that is, greater practice was associated with greater symptoms.  A positive 
association between practice of a coping skill and symptom change can be interpreted in 
the following ways: (1) increased practice of the coping skill increased the symptom 
either directly or indirectly; (2) increased practice of the coping skill was reciprocally 
related to increases in the symptom over time; or (3) a third variable (e.g., relationship 
distress) caused an increase in the practice of the coping skill and an increase in the 
symptom, or vice versa (Tabachnick & Fidell, 2007).  In the following sections I discuss 
these findings.  
 For patients, greater practice of cognitive restructuring during the intervention 
was associated with increased distress related to breathlessness, depressive symptoms, 
and anxiety at 6 weeks post-intervention.  Although these findings are contrary to my 
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hypotheses, numerous authors have argued for the importance of tailoring traditional 
CBT approaches to populations with advanced disease (Campbell & Campbell, 2012; 
Dalton, Keefe, Carlson, & Youngblood, 2004; Greer et al., 2010; Greer et al., 2012).  As 
noted by Greer et al. (2010),  much of the concern involves the types of thoughts that 
patients are attempting to restructure.  If the thoughts are indeed accurate appraisals of 
the situation, then cognitive restructuring may, theoretically, increase distress (Greer et 
al., 2010).  TSM was designed specifically with these concerns in mind.  When choosing 
a coping skill, patients and caregivers were instructed to determine whether a distressing 
thought was accurate or not.  If the thought was accurate (e.g., “my cancer is not 
curable”), self-soothing or emotion-focused strategies were suggested.  Thus, cognitive 
restructuring was only intended to be used for unrealistic thoughts (e.g., “I can’t do 
anything when I’m in pain”).  One assumption of this approach, however, is that the 
patient can accurately assess whether a thought is realistic or not.  It may be erroneous to 
assume that such distinctions are easily ascertained.  Indeed, the purpose of cognitive 
restructuring is to determine if thoughts are realistic or not (Beck & Weishaar, 1989; 
Dobson, 2009); thus, some patients may have attempted to restructure distressing thought 
content only to conclude that the thought was accurate (e.g., “my pain is worse because 
my cancer is spreading”).  
 Another coping skill with effects in the opposite direction of my hypotheses was 
patients’ practice of noticing sounds and thoughts.  Specifically, greater practice of 
noticing sounds and thoughts during the intervention was associated with greater fatigue 
interference and anxiety at 6 weeks post-intervention.  One explanation for these findings 
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is that patients who spent more time noticing their thoughts may have experienced 
increased awareness of their fatigue interference and anxiety.  
Increasing awareness of distressing thought content is one commonality between 
noticing sounds and thoughts and cognitive restructuring.  Both coping skills prompt 
patients to slow down and think about their thoughts, but in different ways.  Specifically, 
noticing sounds and thoughts is a mindfulness-based skill and cognitive restructuring is a 
CBT-based skill.  The original theoretical conceptualizations of these two coping skills 
are quite distinct.  Mindfulness argues for approaching thoughts non-judgmentally 
(Kabat-Zinn & Hanh, 2009): CBT argues for judging thoughts to test their validity (Beck 
& Weishaar, 1989; Dobson, 2009).  Combining the two approaches is often done in 
clinical practice (Shapiro & Carlson, 2009), and there is growing empirical support for 
integrating mindfulness into CBT-based therapies for various clinical issues across a 
variety of patient populations (Gu, Strauss, Bond, & Cavanagh, 2015; Ledesma & 
Kumano, 2009; Segal, Williams, & Teasdale, 2012).  To date, however, the most rigorous 
RCTs of combined mindfulness and CBT interventions for cancer patients have primarily 
included early-stage breast and prostate cancer survivors (for a review see Ledesma & 
Kumano, 2009).  Lung cancer patients are arguably a very different population from 
early-stage breast and prostate cancer survivors (Dudgeon et al., 2001; Greer et al., 2010; 
Linden et al., 2012).  Thus, it is unknown whether symptomatic lung cancer patients 
would benefit from interventions that combine mindfulness and CBT approaches.   
Lastly, there are a few important distinctions between the most effective and least 
effective coping skills.  Specifically, guided imagery and assertive communication are 
highly structured, concrete skills (Dobson, 2009).  In contrast, noticing sounds and 
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thoughts and cognitive restructuring may require a greater level of self-awareness and 
processing ability (Beck & Weishaar, 1989; Kabat-Zinn & Hanh, 2009).  For some lung 
cancer patients, the more complex coping skills may be too difficult to master in brief 
therapy, given that these skills have less directive instructions (e.g., noticing sounds and 
thoughts) and multiple steps (e.g., cognitive restructuring).  Overall, the results suggest 
that noticing sounds and thoughts and cognitive restructuring may have the potential for 
misuse in lung cancer populations; however, these findings should be interpreted very 
cautiously as there are numerous limitations of the current study (see Limitations and 
Future Directions). 
 Guided imagery practice was associated with reductions in certain symptoms for 
patients; however, it was associated with more anxiety for caregivers at 2 weeks post-
intervention.  One potential explanation for these results is that there are important 
distinctions between the challenges that patients face and the challenges that caregivers 
face (Mosher, Bakas, et al., 2013; Mosher, Champion, et al., 2013; Mosher, Hanna, et al., 
2013).  For example, some of the anxious thoughts that caregivers report may be related 
to caregiving tasks (e.g., managing the patient’s medications) that are more appropriately 
addressed with education and problem-solving—not guided imagery.  Practicing guided 
imagery may have caused some caregivers to feel more anxious by negatively reinforcing 
their avoidance of difficult situations.  Those who felt more anxious at 2 weeks post-
intervention may have stopped practicing guided imagery and, thus, reduced their anxiety 
at 6 weeks post-intervention.  Additionally, in contrast to patients’ anxiety, caregivers’ 
anxiety was less stable between baseline and 2 weeks post-intervention and more stable 
between 2 and 6 weeks post-intervention.    Therefore, significant effects were more 
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likely to be detected at 2 weeks post-intervention.  It is also important to note that 
caregivers were generally not reporting clinically meaningful levels of anxiety at any 
time point.  A significant increase in anxiety should not be equated with a meaningful 
increase. 
 
Coping Skills Not Significantly Associated with Symptoms 
With the exception of significant associations previously described, most of the 
coping skills were not significantly related to patient or caregiver symptoms.  There are 
potential explanations for these null findings that warrant consideration, including 
specific issues in the following categories: (1) social desirability, (2) symptom stability, 
(3) pursed lips breathing, (4) distress related to breathlessness, and (5) caregiver distress 
levels.  
First, many of the null findings for patients and caregivers may be related to 
demand characteristics such as social desirability (Carstensen & Cone, 1983; Diener, 
Sandvik, Pavot, & Gallagher, 1991; Nichols & Maner, 2008; Orne, 1962; van de Mortel, 
2008).  Theory (Orne, 1962) and empirical research suggest that some participants desire 
to be “good subjects” and, thus, behave in ways that they believe will confirm the study 
hypotheses (Carstensen & Cone, 1983; Diener et al., 1991; Nichols & Maner, 2008; 
Orne, 1962; van de Mortel, 2008).  Demand characteristics have not been studied in the 
context of dyadic symptom management interventions; however, it is logical that certain 
study designs may increase demand characteristics.  Specifically, in TSM, participants’ 
coping skills practice was assessed during the intervention sessions in front of the 
therapist and the other member of the dyad.  In contrast, all symptoms were assessed for 
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dyad members separately by blinded research assistants.  Participants may have 
misreported their coping skills practice yet accurately reported their symptoms, which 
would attenuate associations.   
Second, symptom stability may explain some of the null findings for patients and 
caregivers.  Specifically, autoregressive models were used to predict the change in 
symptoms over time; however, if a symptom was very stable there was little change to 
predict.  As noted previously, many patient symptoms tended to change the most from 2 
to 6 weeks post-intervention.  This is one explanation for why coping skill effects were 
only detectable at 6 weeks post-intervention for patients.  In contrast, caregiver anxiety 
symptoms changed the most from baseline to 2 weeks post-intervention, increasing the 
likelihood of detecting coping skill effects at this time point.  The lack of symptom 
variability at certain time points highlights concerns about the intervention’s overall 
effectiveness (Mosher et al., under review).  Indeed, the majority of the variance in 
symptoms was generally stable over time for both patients and caregivers.   
Third, pursed lips breathing was the only coping skill that showed no significant 
associations with any of the patient symptoms.  Previous RCTs have found evidence for 
the effectiveness of pursed lips breathing in reducing multiple symptoms in patients with 
chronic obstructive pulmonary disease (Gosselink, 2004; Nield, 2000; Nield et al., 2007; 
Sassi-Dambron, Eakin, Ries, & Kaplan, 1995); however, few studies have tested this 
coping skill with lung cancer patients (Greer et al., 2015).  Recently, Greer et al. (2015) 
conducted a single-group pilot study to test a brief behavioral intervention for 32 
advanced lung cancer patients with moderate to severe breathlessness.  The intervention 
was delivered by nurse practitioners in two sessions and included multiple components, 
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such as psychoeducation on breathlessness, training in pursed lips breathing, directions 
for operating a battery-powered handheld fan, postural techniques for reducing 
breathlessness, and relaxation training (e.g., deep breathing, meditation) for times without 
breathlessness.  Compared to baseline assessments, there were significant improvements 
in breathlessness severity, depressive symptoms, and overall quality of life.  These 
findings should be interpreted cautiously due to the small sample and non-randomized 
design.  Moreover, component-outcome analyses were not reported.  Thus, the degree to 
which pursed lips breathing contributed to symptom change is unknown.  More studies 
testing pursed lips breathing for symptomatic lung cancer patients are needed before 
conclusions can be made regarding this coping skill.   
Fourth, no coping skills were associated with reductions in distress related to 
breathlessness.  There has been mixed evidence from numerous non-pharmacological 
intervention studies targeting distress related to breathlessness and/or breathlessness 
severity in lung cancer patients (Bausewein, Booth, Gysels, & Higginson, 2013; Farquhar 
et al., 2014; Greer et al., 2015; Johnson et al., 2015; Rueda et al., 2011; P. Yates & Zhao, 
2012; Zhao & Yates, 2008).  However, the most effective interventions tend to combine 
psychosocial or behavioral approaches (e.g., anxiety management, postural techniques) 
with medication (e.g., opioids) (Booth, Farquhar, Gysels, Bausewein, & Higginson, 2006; 
Farquhar, Higginson, Fagan, & Booth, 2009; Farquhar et al., 2014).  More rigorous 
research is needed to determine whether distress related to breathlessness in lung cancer 
patients can be effectively managed with non-pharmacological methods.   
 Lastly, none of the coping skills were significantly related to reduced depressive 
or anxiety symptoms for caregivers.  To date, no other studies have reported component-
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outcome analyses for interventions with caregivers of cancer patients.  As noted 
previously, however, there was little change in caregiver symptoms over time which may 
explain the lack of significant findings in the current study.  Indeed, the main outcomes 
of the trial testing TSM showed no improvement in these symptoms compared to an 
attention control condition (Mosher et al., under review).  These findings are somewhat 
inconsistent with meta-analytic evidence (Badr & Krebs, 2013; L. L. Northouse et al., 
2010).  For example, one meta-analysis found that dyadic interventions with cancer 
patients and their caregivers (predominately CBT-based) tended to reduce psychological 
distress (g = 0.21, 95% CI: 0.08 to 0.34, k = 12) for caregivers immediately post-
intervention (Badr & Krebs, 2013).  However, most of these studies included small 
samples, short follow-up time frames, no-treatment control groups (e.g., usual care, wait-
list), and significant attrition.  Moreover, as noted in another meta-analysis, dyadic 
interventions with more sessions tended to produce larger reductions in caregiver 
symptoms, but only when the intervention was focused on coping skills (L. L. Northouse 
et al., 2010).  Thus, four sessions of TSM may not have been enough time to effectively 
train both patients and caregivers in the numerous coping skills.  It is also important to 
note that in the current study there was no distress criterion for caregivers to enter the 
trial.  Indeed, the average caregiver only endorsed mild depressive and anxiety symptoms 
at all time points.  Thus, another explanation for the null results is that there was little 
room for improvement in symptoms among caregivers.  The current findings and main 
intervention outcomes (Mosher et al., under review) suggest TSM is not an effective 
intervention for caregivers of lung cancer patients. 
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Implications from Primary Analyses 
 The current findings have numerous implications for theory.  In support of SCT, 
there were generally moderate to strong correlations between patients’ and caregivers’ 
coping skills practice.  SCT emphasizes the importance of social context (Bandura, 1986, 
2004).  TSM was designed to intervene with both members of the dyad in order to 
enhance opportunities for modeling coping skills and increasing social support.  
In contrast, the majority of the results were not consistent with CBT-based 
approaches to symptom management (Dobson, 2009; Keefe, 1996; Keefe et al., 2010; 
Morley et al., 1999).  Many of the coping skills were not associated with reduced 
symptoms, and a few of the coping skills were associated with greater symptoms.  Brief 
intervention may not have provided lung cancer patients and their caregivers with 
sufficient training and understanding of the coping skills.  An implication from these 
findings is that CBT-based symptom management interventions may need to be tailored 
specifically for lung cancer patients and their caregivers.  
 CBT-based interventions have primarily been tested with cancer patients who do 
not have lung cancer (Faller et al., 2013; Gorin et al., 2012; Hart et al., 2012; Linden & 
Girgis, 2012), an important gap in the literature addressed by TSM (Mosher et al., under 
review).  Compared to patients with other common cancers (e.g., breast, prostate, colon), 
lung cancer patients tend to have lower income, less education, and worse health literacy 
(Forrest, White, Rubin, & Adams, 2014; Halverson et al., 2015; Koay et al., 2013).  
Health literacy refers to a patient’s general ability to gain, understand, and appropriately 
use health-related information (Nielsen-Bohlman, Panzer, & Kindig, 2004).  Health 
literacy concerns were identified in the initial design stages of TSM.  Specifically, lung 
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cancer patients and their family caregivers provided feedback on the intervention 
materials (Mosher, Ott, Hanna, Jalal, & Champion, in press).  Numerous adjustments 
were made to the intervention after some participants reported difficulty reading and 
understanding the materials.  It is unknown as to whether the adjustments were sufficient.  
More research is needed to investigate how CBT-based symptom management strategies 
can be adjusted for patients and caregivers with low health literacy.   
There is also some empirical support for socioeconomic variables (e.g., education, 
income) affecting CBT-based interventions with cancer patients.  Specifically, one RCT 
with newly diagnosed prostate cancer patients (N = 740) found that the effects of a 
psychosocial intervention (e.g., cognitive restructuring, stress-reduction techniques, 
psychoeducation) were significantly different for three groups of patients: older men, 
younger men with high education and income, and younger men with low education and 
income (Chambers, Ferguson, Gardiner, Aitken, & Occhipinti, 2013).  Compared to 
controls, younger men with low education and income did not benefit from the 
intervention and even reported worse adjustment to cancer over the 12-month follow-up.  
The authors argued that the intervention may have heightened patients’ awareness of their 
symptoms and lack of resources.       
Specific directions for future research are discussed in the Limitations and Future 
Directions section; however, a few broader implications for research are worth noting. 
The current study was the first to examine associations between intervention components 
and symptom change in a dyadic intervention for cancer patients and their family 
caregivers.  Numerous authors have advocated for greater emphasis on identifying 
effective intervention components (Andersen et al., 2007; Chan et al., 2012; Czaja et al., 
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2003; Kazantzis et al., 2010; Kazdin, 2007).  Indeed, the results of this study highlight the 
importance of such analyses.  The main outcomes of the trial compared TSM to 
psychoeducation and found no significant between-group differences on any of the 
patient or caregiver symptoms (Mosher et al., under review).  The current study suggests 
that TSM’s effectiveness may have been reduced by certain coping skills, such as pursed 
lips breathing, cognitive restructuring, and noticing sounds and thoughts.  A nuanced 
examination of intervention components was thus informative for future symptom 
management interventions in this population.  However, more rigorous studies are needed 
to test intervention components in an experimental design.  For example, future 
dismantling studies could randomize symptomatic lung cancer patients to various coping 
skill conditions.  Each of the coping skills could be explored in isolation or in various 
combinations.  The current findings suggest a combination of assertive communication 
training and guided imagery should be compared to other coping skills.  Such studies 
would allow for more definitive conclusions regarding differences between skills.  The 
current study can only provide tentative conclusions about associations between coping 
skills and symptoms.  
The current study has multiple implications for clinical practice.  The significant 
effects of coping skills practice were only seen at 6 weeks post-intervention for patients.  
One potential explanation for these findings is that the effects of the coping skills became 
more apparent once treatment had ended.  This was true for effects in the predicted 
directions as well as effects in the opposite direction of my hypotheses.  These findings 
suggest it may be helpful to monitor dyads after treatment has ended.  
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Assertive communication and guided imagery were the most beneficial skills for 
patients in general.  These are straightforward skills that can be taught in a brief amount 
of time.  In contrast, the coping skills that were related to greater symptoms for patients 
were cognitive restructuring and noticing sounds and thoughts.  These two skills arguably 
take more time to master and require more guidance from a therapist to apply them 
appropriately.  Thus, clinicians should be cautious when teaching these skills to lung 
cancer patients.  As noted previously, some distressed cancer patients may have very 
realistic thoughts about their disease and mortality.  Clinicians should be sensitive to 
these concerns and check in regularly to review how patients are using the coping skills 
(e.g., bring thought records to therapy sessions). 
 None of the coping skills were significantly related to decreases in caregivers’ 
depressive or anxiety symptoms.  Indeed, guided imagery practice was related to more 
anxiety for caregivers.  TSM was purposefully designed to train patients and caregivers to 
use the same coping skills for rather disparate concerns and symptoms.  Such an 
approach makes sense in the context of SCT and CBT: basic coping skills can be applied 
to a range of presenting issues (Bandura, 1986, 2004; Dobson, 2009).  However, 
caregivers often experience life changes that are different from patients, and thus they 
may need different types of support (Mosher, Bakas, et al., 2013; Mosher, Champion, et 
al., 2013; Mosher, Hanna, et al., 2013).  Some dyads may present with only the patient 
reporting clinical levels of symptoms.  For example, consider a dyad where the patient 
reports debilitating levels of pain and the caregiver endorses subclinical levels of anxiety.  
The patient and caregiver may both be very focused on reducing the patient’s pain, which 
may also reduce the caregiver’s anxiety.  Thus, rapport may be lost by spending session 
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time focused on the caregiver’s coping strategies.  To avoid such issues, a collaborative 
approach should be used when deciding on treatment goals (Dobson, 2009).  Lastly, some 
caregivers may have been especially hesitant to express their concerns in front of the 
patient.  Literature on the family caregiving role describes how some caregivers desire to 
“be strong” or “positive” for the patient (B. A. Given, Given, & Kozachik, 2001; Kim, 
Baker, Spillers, & Wellisch, 2006; Kim & Given, 2008; P. G. Northouse & Northouse, 
1988; Weitzner, Haley, & Chen, 2000).  For such caregivers, individual therapy may be 
more beneficial than a dyadic intervention.    
 
Strengths 
 This study has numerous strengths worth noting, including study design and 
statistical analyses.  First, to my knowledge, this was the first study to explore 
associations between intervention components and outcomes in a dyadic intervention for 
cancer patients and their caregivers.  Moreover, it included a rigorous longitudinal design 
with blind assessments of patient and caregiver symptoms, training of staff, and 
intervention and assessment fidelity monitoring.  The study also used well-validated and 
reliable symptom measures.  Concerning the analyses, autoregressive path analyses 
allowed for associations to be found that otherwise may have been undetected.  
Specifically, none of the coping skills had significant zero-order correlations with patient 
or caregiver symptoms at 2 or 6 weeks post-intervention.  There were numerous 
statistical trends, however, that were significant in the path analyses after controlling for 
the previous levels of the symptoms.  Isolating the change in symptoms from baseline to 
the follow-ups was crucial for identifying coping skill associations with these outcomes.  
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Limitations and Future Directions 
 The current study has numerous limitations, including the degree of statistical 
power, attrition, lack of dyadic models and covariates, coping skill measurement, and 
study design.  First, each of the path analyses were likely underpowered.  There is 
currently no consensus on calculating power for autoregressive path models (Kline, 2011; 
Lei & Wu, 2007); however, a minimum of 5 participants per pathway is typically 
suggested (Browne & Cudeck, 1992; Kline, 2011).  Each model was under this minimum 
(4.25 participants-to-parameter).  Recently, some have argued that sample size estimates 
for SEM models are too high (Sideridis, Simos, Papanicolaou, & Fletcher, 2014; Wolf, 
Harrington, Clark, & Miller, 2013).  Indeed, multiple simulation studies have found 
parameter estimates for smaller sample sizes (e.g., N = 60) to be stable for exploratory 
purposes (Sideridis et al., 2014; Wolf et al., 2013); moreover, the authors argued that 
underpowered SEM models tend to produce more accurate parameter estimates than 
linear regression or repeated measures ANOVA.  Much of the improvement is related to 
FIML data imputation used in SEM.  In sum, the current results should be interpreted 
cautiously in light of the sample size.  
 Contributing to the power concern, the second major limitation of this study was 
the attrition.  There was approximately 31% attrition from baseline to 6 weeks post-
intervention, which is comparable to other studies of psychosocial interventions with lung 
cancer patients (Chan et al., 2011; Porter et al., 2011).  FIML produces more reliable 
parameter estimates than many other commonly used data imputation methods (Enders, 
2001b; Kline, 2011); however, FIML assumes that data are missing at random (Enders, 
2001a).  Auxiliary variables were initially included in the path analyses in order to 
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enhance the data imputation.  Unfortunately, these variables prevented the models from 
converging and were thus removed from the final analyses.  However, analyses were 
conducted to examine potential differences between those who completed at least one 
follow-up and those who dropped out.  The only significant findings were that caregivers 
who dropped out tended to have lower income and live with the patient.  This finding 
highlights the need for tailoring interventions to lower income populations.  For example, 
caregivers with lower socioeconomic statuses (SES) may be more likely to have trouble 
attending counseling sessions due to various factors (e.g., working multiple jobs, losing 
phone service).  Future studies should explore potential barriers for engaging in treatment 
for family caregivers of lung cancer patients of lower SES.  Some of the attrition analyses 
were underpowered due to small samples and unequal variances within the groups; thus, 
there may be other patterns of missingness that were not detected.  In sum, attrition 
remains a major problem for palliative and other symptom management research (Grande 
& Todd, 2000; Hudson, Aranda, & McMurray, 2001; Preston et al., 2013).  Novel 
approaches are needed to retain participants.  
 A third limitation of this study was that none of the models were dyadic or 
included covariates.  As noted previously, the tested models were already underpowered 
and including dyadic pathways or covariates would result in more pathways than 
participants.  However, there was considerable evidence of dyadic effects, given that 
certain coping skills and symptoms were moderately to strongly correlated within dyads 
(Kenny, Kashy, & Cook, 2006).  Additionally, in prior research, the study outcomes have 
been associated with numerous variables including gender, patient performance status, 
and current treatments (Buccheri et al., 1996; Hagedoorn et al., 2008; Herndon et al., 
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1999; Hirsh et al., 2006; Hopwood & Stephens, 1995; Hopwood & Stephens, 2000; Riley 
et al., 2001).  For example, female cancer patients often report greater symptom 
interference then male patients, and thus may benefit more from certain coping strategies 
(Hagedoorn et al., 2008; Hirsh et al., 2006; Riley et al., 2001).  Concerning patient 
performance status, it is well documented that cancer patients with worse performance 
statuses tend to have higher symptom burden (Buccheri et al., 1996; Hagedoorn et al., 
2008; Herndon et al., 1999; Hirsh et al., 2006; Hopwood & Stephens, 1995; Hopwood & 
Stephens, 2000; Riley et al., 2001).  Performance status could be a third variable 
influencing both the practice of coping skills and the level of symptoms.  For example, a 
patient who spends the majority of the day in bed may be exacerbating his or her pain and 
fatigue and have less energy to practice adaptive coping strategies.  Thus, coping skills 
practice and symptoms may be spuriously connected through performance status.  Lastly, 
some research suggests that various cancer treatments are associated with symptoms in 
lung cancer patients (D. J. Brown et al., 2005; Hopwood & Stephens, 1995; Rolke et al., 
2008; Tanaka et al., 2002b).  For example, following chemotherapy, some cancer patients 
experience an immediate increase in fatigue which tends to decline in the days following 
treatment (Bower et al., 2014; L. F. Brown & Kroenke, 2009).  Thus, treatment factors 
could also serve as third variables impacting coping skills practice and symptom severity.  
Future studies with larger samples are needed to explore potential dyadic effects and 
intervention moderators.       
 A fourth limitation of this study was the measurement of coping skills practice 
during the intervention period.  There are currently no validated measures of coping skills 
practice frequency for cancer patients or their caregivers.  Thus, we developed measures 
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for this study.  Future studies should develop and test measures of coping skills practice 
for this population.  Additionally, reporting biases (e.g., recency, saliency, social 
desirability) may have influenced patients’ and caregivers’ responses.  A calendar and 
tracking sheet were given to each dyad in an attempt to minimize these biases; however, 
the extent to which participants used these materials in unknown.  Moreover, coping 
skills practice was not assessed post-intervention.  Many of the conclusions assumed 
dyads continued to practice the skills after the intervention, which is an empirical 
question that warrants study.  Different methods of assessing coping skills practice (e.g., 
turning in homework logs) should be considered in future work. 
 Final limitations involve the study design, including number of symptoms 
targeted, lack of caregiver distress criterion, and telephone delivery.  First, a range of 
symptoms were chosen as outcomes of this study because it is common for lung cancer 
patients to meet criteria for more than one symptom at a time (Dudgeon et al., 2001; 
Mercadante & Vitrano, 2010; Potter & Higginson, 2004; Tanaka et al., 2002b; Zabora et 
al., 2001); additionally, theory and prior research suggest all of the coping skills taught in 
TSM may reduce each of the targeted symptoms (D. H. Barlow, 2014; J. Barlow et al., 
2002; Jacobsen et al., 2006; Nield et al., 2007; L. L. Northouse et al., 2010; Porter et al., 
2009; Porter et al., 2011).  However, enrolling patients with very disparate symptom 
profiles may have reduced the impact of the intervention.  Indeed, many of the patient 
symptoms were only moderately correlated at the respective time points and some 
associations were non-significant.  The only exceptions were depressive and anxiety 
symptoms, which demonstrated stronger associations than the other symptoms.  Thus, 
symptomatic lung cancer patients may be a more heterogeneous group than assumed, and 
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represent different patient populations.  A more focused intervention may have a larger 
effect.  Future studies should consider intervening on one or two key symptoms (e.g., 
distress or pain).  Additionally, caregivers were not required to meet a distress criterion.  
Thus, the null results for caregivers could be related to minimal variance in their 
depressive and anxiety symptoms.  Future studies should consider including a distress 
criterion for caregivers.  Lastly, TSM was delivered via telephone for numerous reasons 
(e.g., to reduce attrition and burden on dyads); however, this method of delivery may 
have reduced the effectiveness.  More studies are needed comparing telephone-delivered 
interventions to in-person interventions.  
 To summarize, future studies should consider designing and testing a simplified 
symptom management intervention focused on assertive communication and guided 
imagery for symptomatic lung cancer patients and their distressed caregivers.  The 
intervention should target one or two key symptoms, such as distress or pain.  Practice of 
the coping skills should be assessed concurrently with symptoms.  Additionally, attention 
should be given to tailoring intervention content to patients and caregivers with low 
health literacy.  The sample size should be large enough to use dyadic analyses and 
include important covariates (e.g., gender, performance status, cancer treatments).  The 
intervention could be tested in face-to-face and telephone-delivered modalities.  Lastly, 
control groups should be carefully considered, given that comparison groups can greatly 
affect the interpretation of the intervention’s effectiveness (Freedland, Mohr, Davidson, 
& Schwartz, 2011; Schwartz, Chesney, Irvine, & Keefe, 1997).  It may be helpful to 
design studies with more than two conditions (e.g., intervention, attention control, and 
usual care).  Findings from these studies would yield important information regarding the 
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development of effective symptom management interventions for this understudied and 
burdened population.       
 
Conclusion 
 In conclusion, the current study highlights the importance of analyzing 
specific intervention components in relation to specific outcomes in psychosocial 
interventions for cancer patients and their caregivers.  TSM was not significantly 
different from psychoeducation in its impact on patient or caregiver symptoms (Mosher 
et al., under review); my findings suggest the effectiveness of TSM may have been 
reduced by competing and null effects of certain coping skills.  For lung cancer patients, 
future studies should consider focusing on assertive communication and guided imagery, 
as these two coping skills were most consistently associated with reduced symptoms.  In 
contrast, cognitive restructuring and noticing sounds and thoughts tended to be associated 
with worse patient symptoms.  For caregivers, none of the coping skills were associated 
with fewer depressive or anxiety symptoms, but they, on average, had mild levels of 
these symptoms.  More studies are needed to better understand these findings and 
particular caution should be used when applying CBT-based interventions that have not 
been validated in lung cancer populations. 
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Table 1. Patient and Caregiver Characteristics at Baseline 
 Patients  
(n = 51) 
Caregivers  
(n = 51) 
Sex, n (%)   
    Male 23 (45.10) 14 (27.45) 
    Female 28 (54.90) 37 (72.55) 
Age   
    Mean 63.47 56.33 
    SD 7.68 14.09 
    Range 45-85 20-76 
Race, n (%)   
    Non-Hispanic White 45 (88.24) 44 (88.00) 
    Missing 0 (0.00) 1 (1.96) 
Employment status, n (%)   
    Employed full-time or part-time 9 (17.65) 23 (45.10) 
    Retired 25 (49.02) 16 (31.37) 
    Unemployed/other (e.g., sick leave, 
homemaker) 
17 (33.33) 11 (21.57) 
    Missing 0 (0.00) 1 (1.96) 
Household income, n (%)   
    $0 – $20,999 10 (19.61) 8 (15.69) 
    $21,000 – $50,999 12 (23.53) 11 (21.57) 
    $51,000 – $99,999 13 (25.49) 17 (33.33) 
    $100,000 or more 7 (13.73) 9 (17.65) 
    Missing 9 (17.65) 6 (11.76) 
Years of education    
    Mean 12.92  13.94 
    SD 2.22 2.85 
    Range 9-19 8-20 
Married, n (%) 32 (62.75) 38 (74.51) 
Smoking status, n (%)   
    Never smoked  (or smoked < 100 
cigarettes) 
6 (11.76) 27 (52.94) 
    Formerly smoked 34 (66.67) 16 (31.37) 
    Currently smoke  11 (21.57) 8 (15.69) 
Caregiver’s relationship to the patient, n (%)   
   Spouse/partner  32 (62.75) 
   Son/daughter  9 (17.65) 
   Other family member or friend   10 (19.61) 
Caregiver lives with the patient, n (%)  37 (72.55) 
Note.  SD = standard deviation.  
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Table 2. Patient Medical Information at Baseline (n =51) 
Study site, n (%)  
   Indiana University Simon Cancer Center 39 (76.47) 
   Roudebush VA Medical Center 10 (19.61) 
   Eskenazi Hospital in Indianapolis 2 (3.92) 
Type of lung cancer, n (%)  
   NSCLC  44 (86.27) 
   SCLC 7 (13.73) 
Stage of cancer, n (%)  
   Stage I NSCLC 12 (23.53) 
   Stage II NSCLC 4 (7.84) 
   Stage III NSCLC 9 (17.65) 
   Stage IV NSCLC 19 (37.25) 
   Limited-stage SCLC 3 (5.88) 
   Extensive-stage SCLC 4 (7.84) 
   Early-stage (i.e., stage I, II, or limited) 19 (37.25) 
   Advanced-stage (i.e., stage III, IV, or 
extensive) 
32 (62.75) 
Time since diagnosis in years  
   Median 0.57 
   SD 2.12 
   Range 0.07-11.99 
   Missing, n (%) 1 (1.96) 
Treatments received, n (%)  
   Chemotherapy  27 (52.94) 
   Radiation 13 (25.49) 
   Chemoradiation 12 (23.53) 
   Surgery 24 (47.06) 
Patients’ ECOG score  
   Mean 1.43 
   SD 0.92 
   Range 0-3 
Note.  SD = standard deviation; NSCLC = non-small cell lung cancer; SCLC = small cell 
lung cancer; and ECOG = Eastern Cooperative Oncology Group self-reported 
performance status. 
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Table 3. Descriptive Statistics for Patient and Caregiver Coping Skills Practice During 
the Intervention 
Coping skill Patients Caregivers 
Noticing sounds and thoughts   
    n 40 40 
    Mean 12.98 11.74 
    SD 9.73 11.83 
    Range 0-36 0-45 
    Skewness 0.62 1.33 
    Kurtosis -0.70 0.88 
Guided imagery   
    n 40 40 
    Mean 11.59 8.33 
    SD 9.39 7.48 
    Range 0-43 0-32 
    Skewness 1.25 1.29 
    Kurtosis 1.96 1.57 
Pursed lips breathing   
    n 40 40 
    Mean 29.60 15.05 
    SD 32.56 17.22 
    Range 0-133 0-67 
    Skewness 1.79 1.61 
    Kurtosis 2.76 2.35 
Cognitive restructuring    
    n 38 38 
    Mean 9.87 10.82 
    SD 10.64 12.07 
    Range 0-44 0-45 
    Skewness 1.55 1.53 
    Kurtosis 2.07 1.42 
Assertive communication   
    n 38 38 
    Mean 4.83 4.26 
    SD 4.50 3.80 
    Range 0-17 0-15 
    Skewness 1.03 1.33 
    Kurtosis 0.47 1.77 
Note. All statistics computed after outliers were Winsorized.  SD = standard deviation.  
Noticing sounds and thoughts, guided imagery, and pursed lips breathing were assessed 
at the beginning of sessions 2, 3, and 4.  Cognitive restructuring was assessed at the 
beginning of sessions 3 and 4.  Assertive communication was assessed at the beginning 
of session 4.  
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Table 4. Descriptive Statistics for Patient and Caregiver Depressive and Anxiety 
Symptoms 
 Patients  Caregivers 
 
Outcome 
 
Baseline 
2 Week 
Follow-
Up 
6 Week 
Follow-
up 
  
Baseline 
2 Week 
Follow-
Up 
6 Week 
Follow-
up 
Depressive 
symptoms  
       
    n 51 36 35  51 35 35 
    α  0.78 0.70 0.84  0.87 0.84 0.86 
    Mean 7.31 6.36 6.71  5.67 5.09 4.83 
    SD 4.77 3.75 4.77  5.59 4.88 4.90 
    Range 0-21 0-14 0-21  0-23 0-18 0-19 
    Skewness 0.82 0.05 1.10  1.30 1.29 1.27 
    Kurtosis 0.66 -0.86 1.74  1.24 1.17 0.90 
            
Anxiety        
    n 51 36 35  51 35 35 
    α 0.88 0.83 0.86  0.88 0.83 0.87 
    Mean 5.12 3.72 4.06  6.10 5.06 5.00 
    SD 4.89 3.45 3.82  5.19 4.28 4.77 
    Range 0-18 0-14 0-18  0-20 0-14 0-17 
    Skewness 1.15 1.46 1.86  0.92 0.46 1.08 
    Kurtosis 0.52 2.63 4.93  0.39 -0.86 0.49 
Note.  α = alpha coefficient; SD = standard deviation.  
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Table 5. Descriptive Statistics for Patient Outcomes 
 
Outcome 
 
Baseline 
2 Week 
Follow-Up 
6 Week 
Follow-up 
Pain severity    
    n 51 36 35 
    α 0.94 0.92 0.94 
    Mean 2.61 2.24 2.64 
    SD 2.47 2.16 2.49 
    Range 0-9 0-7 0-7 
    Skewness 0.66 0.68 0.46 
    Kurtosis -0.76 -1.01 -1.19 
    
Distress related to breathlessness    
    n 51 36 35 
    α* -- -- -- 
    Mean 1.22 1.33 1.20 
    SD 1.12 1.35 1.23 
    Range 0-4 0-4 0-4 
    Skewness 0.53 0.74 0.60 
    Kurtosis -0.71 -0.56 -0.91 
    
Fatigue interference    
    n 51 36 35 
    α 0.94 0.93 0.94 
    Mean 3.20 2.53 2.87 
    SD 2.46 2.04 2.44 
    Range 0-9 0-7 0-9 
    Skewness 0.61 0.80 1.11 
    Kurtosis -0.79 -0.27 0.50 
Note.  α = alpha coefficient; SD = standard deviation. 
*Distress related to breathlessness was measured using one item.  
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Table 6. Winsorization of Outliers 
 Variable value 
Variable Original Winsorized* 
Patient Coping Skill   
    Assertive communication 40 17 
   
Caregiver Coping Skills   
    Assertive communication 40 15 
    Pursed lips breathing 305 67 
    Cognitive restructuring 82 45 
    Cognitive restructuring 55 40 
*Winsorizing variables involves changing their value to reflect a z-score of +/- 3.
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Appendix A: Measures 
 
Patient Cognitive Status: The Six-Item Screener (SIS)  
(Callahan et al., 2002) 
 
Instructions: I would like to ask you some questions that ask you to use your memory. I 
am going to name three objects. Please wait until I say all three words, then repeat them. 
Remember what they are because I am going to ask you to name them again in a few 
minutes. Please repeat these words for me: APPLE—TABLE—PENNY. (Interviewer 
may repeat words 3 times if necessary but repetition not scored.) 
 
Did patient correctly repeat all three words? 1=Yes  0=No 
   
 Incorrect Correct 
1. What year is this? 0 1 
   
2. What month is this? 0 1 
   
3. What day of the week? 0 1 
   
What were the three objects I asked you to remember?   
   
4. Apple = 0 1 
   
5. Table = 0 1 
   
6. Penny = 0 1 
 
Patient Depressive Symptoms: Patient Health Questionnaire (PHQ-2)  
(Kroenke, Spitzer, & Williams, 2003) 
 
Over the last 2 weeks, how often have you been  
bothered by…  
 Not at 
all 
Several 
days 
More than 
half the 
days 
Nearly 
every 
day 
     
1. Little interest or pleasure in doing 
things 
0 1 2 3 
     
2. Feeling down, depressed, or 
hopeless 
0 1 2 3 
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Patient Anxiety Sympomts: Generalized Anxiety Disorders scale (GAD-2)  
(Kroenke, Spitzer, Williams, & Löwe, 2009) 
 
Over the last 2 weeks, how often have you been  
bothered by…  
 Not at 
all 
Several 
days 
More than 
half the 
days 
Nearly 
every 
day 
     
1. Feeling nervous, anxious or on edge 0 1 2 3 
     
2. Not being able to stop or control 
worrying 
0 1 2 3 
  
Patient Pain Severity and Interference: PEG version of the Brief Pain Inventory-Short 
Form (BPI-SF)  
(Krebs et al., 2009) 
 
1. What number best describes your pain on average in the past week: 
 
   0 1 2 3 4 5 6 7 8 9 10 
No pain        Pain as bad as  
         you can imagine 
 
 
2. What number best describes how, during the past week, pain has interfered  
with your enjoyment of life? 
 
   0 1 2 3 4 5 6 7 8 9 10 
Does not          Completely  
interfere         interferes  
  
 
        
3. What number best describes how, during the past week, pain has interfered  
with your general activity? 
 
   0 1 2 3 4 5 6 7 8 9 10 
Does not          Completely  
interfere         interferes 
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Patient Breathlessness Severity: two items from the Memorial Symptom Assessment 
Scale (MSAS)  
(Portenoy et al., 1994) 
 
During the past week, did you have shortness of breath? 
 
No  Yes 
               
If Yes, how severe was it usually (circle one answer)? 
       
1. Slight 
 
2. Moderate 
 
3. Severe 
 
4. Very severe 
 
Patient Medical Record Review at Baseline: 
 
1. Date of Diagnosis: ____/____/_____  
 
2. Disease Stage - NSCLC 
1 = I 
2 = II 
3 = III 
4 = IV 
 
3. Disease stage - SCLC  
1 = limited stage  
2 = extensive stage  
 
4. Treatments for Lung Cancer: 
 
Surgery: __ Planned   
   __ Received  
 
Chemotherapy: __ Planned  
                       __ Received  
 
Radiation: __ Planned  
            __ Received  
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Chemoradiation: __ Planned  
              __ Received  
 
Baseline and Follow-Up Assessments: 
1. Gender  
Male 
Female 
 
2. What race or ethnicity do you consider yourself to be?  
White  
Black 
Asian 
Hispanic 
Native Hawaiian or other Pacific Islander 
American Indian/Alaskan Native 
Other (specify): _______ 
 
3. What was the last grade you completed in school? 
 Years of Schooling: __ __ 
 
4 . How old are you? 
Years  __ __ __ 
 
5. What is your marital status? 
Married 
Living with partner 
Separated 
Single 
Divorced 
Widowed 
 
6. Thinking about the annual combined income for all family members in your household 
added together, before taxes is it… 
$0-$10,999 
$11,000-$20,999 
$21,000-$30,999 
$31,000-$50,999 
$51,000 to $99,999 
$100,000 or more 
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7. What is your current employment status? 
Employed full-time 
Employed part-time 
Student 
Homemaker 
Retired 
Unemployed, looking for paid work 
Unemployed due to disability 
Other (specify) ________ 
 
8. What is your relationship to the patient? 
Spouse/Partner 
Son/Daughter of the Patient 
Sibling  
Other Relative  
Friend 
Parent of the Patient 
Other 
 
9. Do you live with the patient? 
Yes 
No 
[If caregiver does not live with the patient] How often did you visit the patient during the 
past month? _______ 
 
Patient and Caregiver Smoking Status:  Two items from the Behavioral Risk Factor 
Surveillance System (BRFSS) Questionnaire  
(CDC, 2007) 
 
1. Have you smoked at least 5 packs or 100 cigarettes in your entire life?  
Yes 
No 
 
2. Do you now smoke cigarettes every day, some days, or not at all? 
Every day (Current smoker) 
Some days (Current smoker) 
Not at all (Former) 
 
Patient Performance Status: Self-Reported ECOG Score  
(Oken et al., 1982) 
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Over the past month I would generally rate my activity as… 
 0- Normal with no limitations 
 1- Not my normal self, but able to be up and about with fairly normal activities 
 2- Not feeling up to most things, but in bed or chair less than half the day 
 3- Able to do little activity and spend most of the day in bed or chair 
 4- Pretty much bedridden, rarely out of bed 
 
Patient and Caregiver Depressive Symptoms: Patient Health Questionnaire (PHQ-8) 
(Kroenke, Spitzer, et al., 2010; Löwe, et al., 2004)      
Over the last 2 weeks, how often have you been  
bothered by…  
 Not at 
all 
Several 
days 
More than 
half the 
days 
Nearly 
every 
day 
     
1. Little interest or pleasure in doing 
things 
0 1 2 3 
     
2. Feeling down, depressed, or hopeless 0 1 2 3 
     
3. Trouble falling asleep or staying 
asleep, or sleeping too much 
0 1 2 3 
     
4. Feeling tired or having little energy 0 1 2 3 
     
5. Poor appetite or overeating  0 1 2 3 
     
6. Feeling bad about yourself – or that 
you  
are a failure or have let yourself or your  
family down 
0 1 2 3 
     
7. Trouble concentrating on things, 
such as 
reading the newspaper or watching 
television 
0 1 2 3 
     
8. Moving or speaking so slowly that 
other  
people could have noticed? Or the 
opposite –being so fidgety or restless 
that you have been moving around a lot 
more than usual 
0 1 2 3 
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Patient and Caregiver Anxiety Symptoms: Generalized Anxiety Disorders scale (GAD-7)  
(Kroenke, Spitzer, et al., 2010; Kroenke, Spitzer, Williams, Monahan, & Löwe, 2007)      
 
Over the last 2 weeks, how often have you been  
bothered by…  
 Not at 
all 
Several 
days 
More than 
half the 
days 
Nearly 
every 
day 
     
1. Feeling nervous, anxious or on edge 0 1 2 3 
     
2. Not being able to stop or control 
worrying 
0 1 2 3 
     
3. Worrying too much about different 
things 
0 1 2 3 
     
4. Having trouble relaxing 0 1 2 3 
     
5. Being so restless that it is hard to sit 
still 
0 1 2 3 
     
6. Becoming easily annoyed or irritable 0 1 2 3 
     
7. Feeling afraid as if something awful 
might happen 
0 1 2 3 
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Patient Pain Severity: The Brief Pain Inventory – Short Form (BPI-SF) 
(Cleeland et al., 1994)  
 
  
1. Please rate your pain by choosing the one number that best describes your pain at 
its worst in the last 24 hours. 
 
0 1 2 3 4 5 6 7 8 9 10   
No pain         Pain as bad as 
you can imagine 
2. Using response scale C, please rate your pain by choosing the one number that 
best describes your pain at its least in the last 24 hours. 
 
0 1 2 3 4 5 6 7 8 9 10   
No pain         Pain as bad as 
you can imagine 
 
  
3. Please rate your pain by choosing the one number that best describes your pain on 
the average. 
 
0 1 2 3 4 5 6 7 8 9 10   
No pain         Pain as bad as 
you can imagine 
 
  
4. Please rate your pain by choosing the one number that tells how much pain you 
have right now. 
 
0 1 2 3 4 5 6 7 8 9 10   
No pain         Pain as bad as 
you can imagine 
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Patient Distress Related to Breathlessness: Two items from the Memorial Symptom 
Assessment Scale (MSAS)  
(Portenoy et al., 1994)      
 
During the past week did you have shortness of breath? 
Yes  
No 
 
If Yes: How much did it DISTRESS or BOTHER you? 
0 = Not at all 
1 = A little bit 
2 = Somewhat 
3 = Quite a bit  
4 = Very much 
 
Patient Fatigue Interference: Fatigue Symptom Inventory (FSI): Interference Subscale 
(Hann, Denniston, & Baker, 2000)      
 
1.  Rate how much, in the past week, fatigue interfered with your general level of activity. 
 
0 1 2 3 4 5 6 7 8 9 10   
No 
interference 
        Extreme 
interference 
 
2. Rate how much, in the past week, fatigue interfered with your ability to bathe 
 and dress yourself. 
 
0 1 2 3 4 5 6 7 8 9 10   
No 
interference 
        Extreme 
interference 
 
3. Rate how much, in the past week, fatigue interfered with your normal work activity  
(includes both work outside the home and housework). 
 
0 1 2 3 4 5 6 7 8 9 10   
No 
interference 
        Extreme 
interference 
 
 
4. Rate how much, in the past week, fatigue interfered with your ability to concentrate. 
 
0 1 2 3 4 5 6 7 8 9 10   
No 
interference 
        Extreme 
interference 
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5. Rate how much, in the past week, fatigue interfered with your relations with other 
people. 
 
0 1 2 3 4 5 6 7 8 9 10   
No 
interference 
        Extreme 
interference 
 
6. Rate how much, in the past week, fatigue interfered with your enjoyment of life. 
 
0 1 2 3 4 5 6 7 8 9 10   
No 
interference 
        Extreme 
interference 
 
7. Rate how much, in the past week, fatigue interfered with your mood. 
 
0 1 2 3 4 5 6 7 8 9 10   
No 
interference 
        Extreme 
interference 
 
Assessment of Patient and Caregiver Coping Skills Practice During Intervention 
Sessions: 
 
Instructions: Ok, now I am going to ask both of you about relaxation and other skills 
that you may or may not have practiced during the past week.  If you wrote down the 
number of times you practiced the skills on Handout 3D or the calendar in the back of 
your notebook, please look at it now as I read the questions.  Are you ready? 
 
Noticing Sounds and Thoughts: 
1. During the past week, did you practice relaxation by listening to sounds around 
you or noticing your own thoughts without judging them? How many times did 
you do this during the past week? (Note: write down “0” if they did not do the 
exercise. If only the patient or caregiver responds, say, “What about you Mr./Ms. 
[insert last name of other person]?”) 
___ Times for Patient 
___ Times for Caregiver 
Guided Imagery: 
2. During the past week, did you imagine yourself in a peaceful place? How many 
times did you do this during the past week? 
___ Times for Patient 
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___ Times for Caregiver 
Pursed Lips Breathing: 
3. During the past week, did you use pursed lips breathing? How many times did 
you do this during the past week? 
___ Times for Patient 
___ Times for Caregiver 
Cognitive Restructuring: 
4. During the past week, did you replace your negative thoughts with more helpful 
thoughts? (Say, “We discussed this using Handout 2B” if they do not recall the 
technique.) How many times did you do this during the past week? 
___ Times for Patient 
___ Times for Caregiver 
Assertive Communication: 
5. During the past week, did you practice using the communication skills that we 
discussed? How many times did you do this during the past week? 
___ Times for Patient 
___ Times for Caregiver
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Appendix B: LISREL Syntax 
Model #1 Patient Pain Severity  
 
DA NO=51 NI=8 MA=CM ME=ML 
RA FI=Pain.lsf 
 
LA 
PainSev1 PainSev2 PainSev0 MindfulP ImageP LipsP CogRestP AssertP 
 
SE 
PainSev1 PainSev2 PainSev0 MindfulP ImageP LipsP CogRestP AssertP/ 
MO NY=2 NX=6 BE=SD,FI GA=FU,FI PH=SY,FI PS=SY,FR 
 
!Autoregressive paths 
FR GA(1,1) BE(2,1) 
 
!Freeing HW paths 
FR GA(1,2) GA(2,2) 
FR GA(1,3) GA(2,3) 
FR GA(1,4) GA(2,4) 
FR GA(1,5) GA(2,5) 
FR GA(1,6) GA(2,6)  
 
!Freeing predictors to correlate 
FR PH(2,3)PH(2,4)PH(2,5)PH(2,6) 
FR PH(3,4)PH(3,5)PH(3,6) 
FR PH(4,5)PH(4,6) 
FR PH(5,6) 
 
!Fixing F#1 and F#2 covariance to zero 
FI PS(1,2) 
 
PD 
OU EF SE 
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Model #2 Patient Distress Related to Breathlessness 
 
DA NO=51 NI=8 MA=CM ME=ML 
RA FI=Dyspnea.lsf 
 
LA 
DysDis1 DysDis2 DysDis0 MindfulP ImageP LipsP CogRestP AssertP 
 
SE 
DysDis1 DysDis2 DysDis0 MindfulP ImageP LipsP CogRestP AssertP/ 
MO NY=2 NX=6 BE=SD,FI GA=FU,FI PH=SY,FI PS=SY,FR 
 
!Autoregressive paths 
FR GA(1,1) BE(2,1) 
 
!Freeing HW paths 
FR GA(1,2) GA(2,2) 
FR GA(1,3) GA(2,3) 
FR GA(1,4) GA(2,4) 
FR GA(1,5) GA(2,5) 
FR GA(1,6) GA(2,6)  
 
!Freeing predictors to correlate 
FR PH(2,3)PH(2,4)PH(2,5)PH(2,6) 
FR PH(3,4)PH(3,5)PH(3,6) 
FR PH(4,5)PH(4,6) 
FR PH(5,6) 
 
!Fixing F#1 and F#2 covariance to zero 
FI PS(1,2) 
 
PD 
OU EF SE 
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Model #3 Patient Fatigue Interference  
 
DA NO=51 NI=8 MA=CM ME=ML 
RA FI=FSIAllHW.lsf 
 
LA 
FSIInt1 FSIInt2 FSIInt0 MindfulP ImageP LipsP CogRestP AssertP 
 
SE 
FSIInt1 FSIInt2 FSIInt0 MindfulP ImageP LipsP CogRestP AssertP/ 
MO NY=2 NX=6 BE=SD,FI GA=FU,FI PH=SY,FI PS=SY,FR 
 
!Autoregressive paths 
FR GA(1,1) BE(2,1) 
 
!Freeing HW paths 
FR GA(1,2) GA(2,2) 
FR GA(1,3) GA(2,3) 
FR GA(1,4) GA(2,4) 
FR GA(1,5) GA(2,5) 
FR GA(1,6) GA(2,6)  
 
!Freeing predictors to correlate 
FR PH(2,3)PH(2,4)PH(2,5)PH(2,6) 
FR PH(3,4)PH(3,5)PH(3,6) 
FR PH(4,5)PH(4,6) 
FR PH(5,6) 
 
!Fixing F#1 and F#2 covariance to zero 
FI PS(1,2) 
 
PD 
OU EF SE 
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Model #4 Patient Depressive Symptoms 
 
DA NO=51 NI=8 MA=CM ME=ML 
RA FI=PtPHQAllHW.lsf 
 
LA 
PHQP1 PHQP2 PHQP0 MindfulP ImageP LipsP CogRestP AssertP 
 
SE 
PHQP1 PHQP2 PHQP0 MindfulP ImageP LipsP CogRestP AssertP/ 
MO NY=2 NX=6 BE=SD,FI GA=FU,FI PH=SY,FI PS=SY,FR 
 
!Autoregressive paths 
FR GA(1,1) BE(2,1) 
 
!Freeing HW paths 
FR GA(1,2) GA(2,2) 
FR GA(1,3) GA(2,3) 
FR GA(1,4) GA(2,4) 
FR GA(1,5) GA(2,5) 
FR GA(1,6) GA(2,6)  
 
!Freeing predictors to correlate 
FR PH(2,3)PH(2,4)PH(2,5)PH(2,6) 
FR PH(3,4)PH(3,5)PH(3,6) 
FR PH(4,5)PH(4,6) 
FR PH(5,6) 
 
!Fixing F#1 and F#2 covariance to zero 
FI PS(1,2) 
 
PD 
OU EF SE 
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Model #5 Patient Anxiety Symptoms 
 
DA NO=51 NI=8 MA=CM ME=ML 
RA FI=PtGADAllHW.lsf 
 
LA 
GADP1 GADP2 GADP0 MindfulP ImageP LipsP CogRestP AssertP 
 
SE 
GADP1 GADP2 GADP0 MindfulP ImageP LipsP CogRestP AssertP/ 
MO NY=2 NX=6 BE=SD,FI GA=FU,FI PH=SY,FI PS=SY,FR 
 
!Autoregressive paths 
FR GA(1,1) BE(2,1) 
 
!Freeing HW paths 
FR GA(1,2) GA(2,2) 
FR GA(1,3) GA(2,3) 
FR GA(1,4) GA(2,4) 
FR GA(1,5) GA(2,5) 
FR GA(1,6) GA(2,6)  
 
!Freeing predictors to correlate 
FR PH(2,3)PH(2,4)PH(2,5)PH(2,6) 
FR PH(3,4)PH(3,5)PH(3,6) 
FR PH(4,5)PH(4,6) 
FR PH(5,6) 
 
!Fixing F#1 and F#2 covariance to zero 
FI PS(1,2) 
 
PD 
OU EF SE 
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Model #6 Caregiver Depressive Symptoms 
 
DA NO=51 NI=8 MA=CM ME=ML 
RA FI=CGPHQAllHW.lsf 
 
LA 
PHQC1 PHQC2 PHQC0 MindfulC ImageC LipsC CogRestC AssertC 
 
SE 
PHQC1 PHQC2 PHQC0 MindfulC ImageC LipsC CogRestC AssertC/ 
MO NY=2 NX=6 BE=SD,FI GA=FU,FI PH=SY,FI PS=SY,FR 
 
!Autoregressive paths 
FR GA(1,1) BE(2,1) 
 
!Freeing HW paths 
FR GA(1,2) GA(2,2) 
FR GA(1,3) GA(2,3) 
FR GA(1,4) GA(2,4) 
FR GA(1,5) GA(2,5) 
FR GA(1,6) GA(2,6)  
 
!Freeing predictors to correlate 
FR PH(2,3)PH(2,4)PH(2,5)PH(2,6) 
FR PH(3,4)PH(3,5)PH(3,6) 
FR PH(4,5)PH(4,6) 
FR PH(5,6) 
 
!Fixing F#1 and F#2 covariance to zero 
FI PS(1,2) 
 
PD 
OU EF SE 
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Model #7 Caregiver Anxiety Symptoms 
 
DA NO=51 NI=8 MA=CM ME=ML 
RA FI=PtGADAllHW.lsf 
 
LA 
GADC1 GADC2 GADC0 MindfulC ImageC LipsC CogRestC AssertC 
 
SE 
GADC1 GADC2 GADC0 MindfulC ImageC LipsC CogRestC AssertC/ 
MO NY=2 NX=6 BE=SD,FI GA=FU,FI PH=SY,FI PS=SY,FR 
 
!Autoregressive paths 
FR GA(1,1) BE(2,1) 
 
!Freeing HW paths 
FR GA(1,2) GA(2,2) 
FR GA(1,3) GA(2,3) 
FR GA(1,4) GA(2,4) 
FR GA(1,5) GA(2,5) 
FR GA(1,6) GA(2,6)  
 
!Freeing predictors to correlate 
FR PH(2,3)PH(2,4)PH(2,5)PH(2,6) 
FR PH(3,4)PH(3,5)PH(3,6) 
FR PH(4,5)PH(4,6) 
FR PH(5,6) 
 
!Fixing F#1 and F#2 covariance to zero 
FI PS(1,2) 
 
PD 
OU EF SE 
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service to the department, Department of Psychology, IUPUI 
 
January 2014 Recipient of the Alumnus of the Year Award, awarded to one 
alumnus annually in recognition of character, scholarship, and 
leadership, Department of Psychology, Indiana Wesleyan University 
 
Fall 2010 
 
Elected Who’s Who among students in America’s colleges and 
universities 
 
CURRENT RESEARCH INTERESTS 
 Psychosocial interventions to improve physical and psychological health in cancer  
patients and their family caregivers  
 Psychosocial intervention mechanisms  
 Meaning in life in cancer patients 
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  PEER-REVIEWED PUBLICATIONS 
1.  Mosher, C. E., Winger, J. G., Hanna, N., Jalal, S. I., Einhorn, L. H., Birdas, T. J., 
Ceppa, D. P., Kesler, K. A., Schmitt, J., Kashy, D. A., & Champion, V. L. (in 
press). Randomized pilot trial of a telephone symptom management intervention 
for symptomatic lung cancer patients and their family caregivers. Journal of Pain 
and Symptom Management.  
 
2.  Christy, S. M., Winger, J. G., Raffanello, E. W., Halpern, L. H., Danoff-Burg, S., & 
Mosher, C. E. (in press). The role of anticipated regret and health beliefs in HPV 
vaccination intention among young adults. Journal of Behavioral Medicine. doi: 
10.1007/s10865-016-9716-z 
 
3.  Mosher, C. E., Winger, J. G., Given, B. A., Helft, P. R., & O’Neil, B. H. (in press). 
Mental health outcomes during colorectal cancer survivorship: A review of the 
literature. Psycho-Oncology. doi: 10.1002/pon.3954 
 
4.  Winger, J. G., Christy, S. M., & Mosher, C. E. (in press). Associations of health 
behaviors with human papillomavirus vaccine uptake, completion, and intentions 
among female undergraduate students. Journal of Health Psychology. doi: 
10.1177/1359105315569093 
 
5.  Winger, J. G., Adams, R. N., & Mosher, C. E. (2016). Relations of meaning in life 
and sense of coherence to distress in cancer patients: A meta-analysis. Psycho-
Oncology, 25, 2-10. doi: 10.1002/pon.3798 
 
6.  Adams, R. N., Winger, J. G., & Mosher, C. E. (2015). A meta-analysis of the 
relationship between social constraints and distress in cancer patients. Journal of 
Behavioral Medicine, 38, 294-305. doi: 10.1007/s10865-014-9601-6 
 
7.  Winger, J. G., Mosher, C. E., Rand, K. L., Morey, M. C., Snyder, D. C., & Demark-
Wahnefried, W. (2014). Diet and exercise intervention adherence and health-
related outcomes among older long-term breast, prostate, and colorectal cancer 
survivors. Annals of Behavioral Medicine, 48, 235-245. doi: 10.1007/s12160-014-
9598-7 
  
8.  Mosher, C. E., Winger, J. G., Hanna, N., Jalal, S. I., Fakiris, A. J., Einhorn, L. H., 
Birdas, T. J., Okereke, I. C., Kesler, K. A., & Champion, V. L. (2014). Barriers to 
mental health service use and preferences for addressing emotional concerns 
among lung cancer patients. Psycho-Oncology, 23, 812-819. doi: 
10.1002/pon.3488 
 
9.  Steenbergh, T. A., Runyan, J. D., Daugherty, D. A., & Winger, J. G. (2012). 
Neuroscience exposure and perceptions of client responsibility among addictions 
counselors. Journal of Substance Abuse Treatment, 42, 421-428. doi: 
10.1016/j.jsat.2011.09.015  
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 MANUSCRIPTS IN PREPARATION 
10.  Tometich, D. B., Mosher, C. E., Winger, J. G., Snyder, D. C., & Demark-
Wahnefried, W. (2016). Exercise and dietary behavior in a randomized controlled 
trial of weight loss in overweight mothers with breast cancer and their overweight 
daughters. Manuscript in preparation. 
 
PRESENTATIONS AT SCIENTIFIC MEETINGS 
1.  Chinh, K., Mosher, C. E., Winger, J. G., Sloane, R., Snyder, D. C., Jones, L., & 
Demark-Wahnefried, W. (2016, June). Relations of self-efficacy to health 
behaviors in a weight loss intervention trial for breast cancer survivors and their 
daughters. Poster to be presented at the 8th Biennial Cancer Survivorship 
Research Conference, Washington, DC. 
 
2.  Winger, J. G., & Mosher, C. E. (2016, April). Relations of coping skills practice to 
symptom change in a psychosocial symptom management intervention for lung 
cancer patients and their family caregivers. Poster presented at the 2016 Society 
of Behavioral Medicine Annual Meeting, Washington, DC. 
 
3.  Mosher, C. E., Winger, J. G., Hanna, N., Kashy, D., Champion, V. L. (2015, 
October). Randomized pilot trial of a telephone symptom management 
intervention for lung cancer patients and their family caregivers. Poster presented 
at the 2015 Annual Kathleen Foley Palliative Care Retreat, Jackson Hole, WY.  
 
4.  Winger, J. G., Adams, R. N., & Mosher, C. E. (2015, April). Relations of meaning in 
life and sense of coherence to distress in cancer patients: A meta-analysis. Poster 
presented at the 2015 Society of Behavioral Medicine Annual Meeting, San 
Antonio, TX. 
 
5.  Winger, J. G., Christy, S. M., Blatsioris, A. D., & Mosher, C. E. (2014, April). 
Health behaviors associated with HPV vaccine receipt and intentions among 
undergraduate women. Poster presented at the 2014 Society of Behavioral 
Medicine Annual Meeting, Philadelphia, PA. 
 
6.  Mosher, C. E., & Winger, J. G. (2013, April). Support service use and interest in 
support services among lung cancer patients. Poster presented at the 2013 
Translational Science Meeting, Washington, DC. 
 
7.  Van Antwerp, L. R., Winger, J. G., Christy, S. M., & Mosher, C. E. (2013, April). 
Relationships between health behaviors and HPV vaccine receipt and intentions 
among undergraduate women. Poster presented at the IUPUI Research Day 2013, 
Indianapolis, IN. 
 
8.  Winger, J. G., & Mosher, C. E. (2013, March). Support service use among lung 
cancer patients. Poster presented at the 2013 Society of Behavioral Medicine 
Annual Meeting, San Francisco, CA.  
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9.  Winger, J. G., Mosher, C. E., Bakas, T., & Champion, V. L. (2012, April). Physical 
and mental health and life changes among family caregivers of lung cancer 
patients. Poster presented at the 2012 Society of Behavioral Medicine Annual 
Meeting, New Orleans, LA. 
 
10.  Winger, J. G., Steenbergh, T.A., Runyan, J., & Daugherty, D. (2010, November). 
Therapists’ views of spirituality in drug and alcohol treatment. Poster presented at 
the annual convention of the Association for Behavioral & Cognitive Therapies, 
San Francisco, CA. 
 
11.  Daugherty, D., Winger, J. G., Steenbergh, T.A., &  Runyan, J. (2010, October). 
Therapists’ views of clients’ responsibility for alcohol and drug addiction. Poster 
presented at Addictions Conference 2010, Arlington, VA. 
 
12.  Winger, J. G., Steenbergh, T.A., Runyan, J., & Daugherty, D. (2010, April). 
Therapists’ views of clients’ responsibility for alcohol and drug addiction. Paper 
presented at the Indiana Wesleyan University Celebration of Scholarship, Marion, 
IN. 
 
13.  Winger, J. G., Haak, C., Pfleegor, J. & Steenbergh, T. (2009, April). Cyberporn use 
and loneliness among undergraduate college students. Poster presented at the 
Butler University Undergraduate Research Conference, Indianapolis, IN. 
 
ORAL PRESENTATIONS 
1.  Winger, J. G. (2015, February). The case of “Jacob.” Clinical case presentation at 
the Clinical Psychology Proseminar. IUPUI, Indianapolis, IN.  
 
2.  Winger, J. G. (2014, November). The relationship between intervention adherence 
and symptom change in a psychosocial symptom management intervention for 
lung cancer patients and their family caregivers. Research presentation at the 
Behavioral Cooperative Oncology Group Annual Fall Conference. IUPUI, 
Indianapolis, IN. 
 
3.  Winger, J. G. (2014, January). Behavioral medicine: Research and practice. Invited 
lecture at the Annual Psychology Colloquium, Indiana Wesleyan University, 
Marion, IN.  
 
4.  Winger, J. G. (2013, November). The relationship between spirituality and distress in 
advanced cancer patients. Research presentation at the Behavioral Cooperative 
Oncology Group Annual Fall Conference. IUPUI, Indianapolis, IN. 
 
5.  Winger, J. G. (2013, September). Diet and exercise intervention adherence and 
health-related outcomes among older long-term breast, prostate, and colorectal 
cancer survivors. Research presentation at the Clinical Psychology Proseminar. 
IUPUI, Indianapolis, IN.  
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6.  Winger, J. G. (2013, August). Behavioral intervention adherence. Research 
presentation at the 2013 Behavioral Cooperative Oncology Group Summer 
Retreat. Michigan State University, Lansing, MI.  
 
GRANTS 
April 2016 IUPUI School of Science Student Funding Award ($400; travel 
grant for the 2016 Society of Behavioral Medicine Annual Meeting) 
 
April 2016 IUPUI School of Science Graduate Student Council Travel Grant 
($300; travel grant for the 2016 Society of Behavioral Medicine 
Annual Meeting) 
 
March 2016 IUPUI Graduate-Professional Educational Grant ($500; travel 
grant for the 2016 Society of Behavioral Medicine Annual Meeting) 
 
March 2015 IUPUI Graduate-Professional Educational Grant ($500; travel 
grant for the 2015 Society of Behavioral Medicine Annual Meeting) 
 
March 2015 IUPUI School of Science Graduate Student Council Travel Grant 
($500; travel grant for the 2015 Society of Behavioral Medicine 
Annual Meeting) 
 
March 2015 IUPUI School of Science Student Funding Award ($400; travel 
grant for the 2015 Society of Behavioral Medicine Annual Meeting) 
 
March 2014 IUPUI School of Science Student Funding Award ($1247; travel 
grant for 2014 Dyadic Data Analysis Workshop, Michigan State 
University) 
 
March 2013 IUPUI School of Science Graduate Student Council Travel Grant 
($600; travel grant for the 2013 Society of Behavioral Medicine 
Annual Meeting) 
 
March 2013 IUPUI Graduate and Professional Student Government 
Educational Enhancement Grant ($500; travel grant for the 2013 
Society of Behavioral Medicine Annual Meeting) 
 
May 2012 IUPUI School of Science Graduate Student Council Travel Grant 
($300; travel grant for the 2012 Society of Behavioral Medicine 
Annual Meeting) 
 
April 2012 IUPUI Graduate and Professional Student Government 
Educational Enhancement Grant ($500; travel grant for the 2012 
Society of Behavioral Medicine Annual Meeting) 
182 
 
 
April 2012 IUPUI Department of Psychology Clinical Psychology Program 
Travel Grant ($300; travel grant for the 2012 Society of Behavioral 
Medicine Annual Meeting) 
 
August 2009 Lilly Undergraduate Research Grant ($800; Indiana Wesleyan 
University) 
 
RESEARCH EXPERIENCE 
Fall 2011- 
Summer 2013 
Graduate Research Assistant  
Department of Psychology, IUPUI 
Indianapolis, IN  
 
Duties: Recruited participants and conducted assessments for 
research on the support needs and preferences of lung 
cancer patients; conducted assessments for a pilot 
trial testing a telephone-delivered symptom 
management intervention for lung cancer patients and 
their family caregivers; conducted literature searches 
and compiled measures; collected information from 
medical records; maintained study databases and 
participant files; assisted with manuscript and grant 
preparation. 
 
Supervisor: Catherine E. Mosher, Ph.D., Department of 
Psychology, IUPUI 
 
 
Spring 2008-
Summer 2011 
Undergraduate Research Assistant 
Department of Psychology, Indiana Wesleyan University 
Marion, IN  
 
Duties: Assisted with data collection, data analysis, 
manuscript writing and presentations for projects 
concerning neuroscience exposure and addiction 
counselors’ perceptions of client responsibility.  
 
Supervisor: Timothy A. Steenbergh, Ph.D., Department of 
Psychology, Indiana Wesleyan University 
 
 
  EDITORIAL ACTIVITIES 
 Psycho-Oncology (three mentored reviews, 2013 - 2015) 
 Annals of Behavioral Medicine (one mentored review, 2014) 
 Journal of Consulting and Clinical Psychology (one mentored review, 2013) 
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RESEARCH WORKSHOPS AND TRAININGS 
August 2015 Mixed Effects Longitudinal Modeling (2 days) 
Kevin King, Ph.D., University of Washington  
 
July 2015 Advanced Scientific Writing from the Reader’s Perspective (1 day) 
George D. Gopen, PhD., Professor Emeritus, Duke University  
 
September 
2014  
Mediation, Moderation, & Conditional Process Analysis Workshop 
(2 days) Andrew F. Hayes, Ph.D., Professor, The Ohio State 
University  
 
June 2014  Dyadic Data Analysis Workshop (5 days)  
Deborah Kashy, Ph.D., Professor, Michigan State University  
 
August 2013  Introduction to Meta-analysis Workshop (3 days)  
Noel Card, Ph.D., Associate Professor, University of Arizona  
 
August 2013-
Present  
Cancer Control Educational Series  
Monthly lectures on research topics related to cancer prevention and 
control. 
  
July 2013  Scientific Writing from the Reader’s Perspective (1 day)  
George D. Gopen, PhD., Professor Emeritus, Duke University  
 
July 2013  Grant Writers’ Seminars & Workshops (2 days) 
David C. Morrison, Ph.D., Professor, University of Missouri Kansas 
City  
 
August 2012  Introduction to Structural Equation Modeling Workshop (3 days)  
Gregory Hancock, Ph.D., Professor, University of Maryland  
 
August 2011-
August 2013  
Oncology Faculty Research Group  
Monthly faculty research group meetings led by Victoria Champion, 
Ph.D., RN, FAAN. Attendees provided feedback on peers’ research 
proposals and grant applications.  
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CLINICAL EXPERIENCE 
Fall 2014 Integrated Primary Care Unit  
Psychology Practicum Student 
Roudebush VA Medical Center 
Indianapolis, IN  
 
Duties: Provided evidence-based individual therapy 
(Cognitive-Behavioral Therapy, Supportive  
Psychotherapy, Acceptance and Commitment  
Therapy, Mindfulness-Based Psychotherapy) to  
veterans in an integrated primary care setting.  
Administered neuropsychological assessments, 
provided test feedback to veterans, and consulted with 
primary care physicians. Participated in an 8-week 
Mindfulness-Based Stress Reduction (MBSR) group. 
 
Supervisor: Jay Summers, Ph.D. 
 
 
Summer 2014 Integrated Primary Care Unit 
Psychology Practicum Student 
Roudebush VA Medical Center 
Indianapolis, IN  
 
Duties: Provided evidence-based individual therapy  
(Cognitive-Behavioral Therapy, Supportive  
Psychotherapy, Acceptance and Commitment  
Therapy) to veterans in an integrated primary care  
setting. Administered neuropsychological 
assessments, provided test feedback to veterans, and 
consulted with primary care physicians.  
Co-lead Managing Overweight/Obese Veterans  
Everywhere (MOVE!) groups. Participated in 
multidisciplinary treatment team meetings.  
 
Supervisor: Jennifer Lydon-Lam, Ph.D. 
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Fall 2013 Inpatient Palliative Care Unit 
Psychology Practicum Student 
Roudebush VA Medical Center 
Indianapolis, IN  
 
Duties: Provided evidence-based family and individual  
therapy (Cognitive-Behavioral Therapy, Supportive 
Psychotherapy, Grief Counseling, and Symptom 
Management) to adult medical patients on an inpatient 
palliative care unit. Participated in multidisciplinary 
treatment team meetings.  
 
Supervisor: Samantha Outcalt, Ph.D., Department of Psychiatry,  
Indiana University School of Medicine 
 
 
Spring 2013  Inpatient Psychiatric Unit  
Psychology Practicum Student 
Larue D. Carter Memorial Hospital 
Indianapolis, IN  
 
Duties: Provided evidence-based group and individual therapy 
(Cognitive-Behavioral Therapy, Dialectical  
Behavioral Therapy, Behavioral Therapy) to adult  
patients in an inpatient setting. Co-facilitated Anger 
Management, Severe Mental Illness Stigma, and  
Stepping Stones (Transition Skills) groups.  
Administered assessments to individuals with severe  
mental illness. Participated in multidisciplinary  
treatment team meetings.  
 
Supervisor: Sarah Landsberger, Ph.D., Department of Psychiatry,  
Indiana University School of Medicine 
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Fall 2012  Neuropsychological Assessment  
Psychology Practicum Student 
Beacon Psychology Service, LLC 
Carmel, IN  
 
Duties: Administered various assessments of intelligence,  
academic achievement, personality, 
attention/concentration, presence of autism, and  
motor functioning to children ages 4-18;  
scored assessments; wrote integrated reports of  
assessment findings; conducted intake interviews  
with children and parents; provided assessment  
findings to parents and children; co-facilitated a  
social skills group for boys ages 14-17 who had  
autism spectrum disorder. 
 
Supervisor: Jennifer Horn, Ph.D., HSPP, Beacon Psychological  
Services 
 
 
Fall 2010- 
Spring 2011 
Inpatient Psychiatric Hospital  
Mental Health Technician  
Cedar Springs Hospital  
Colorado Springs, CO  
 
Duties: Provided evidence-based group counseling 
regarding coping skills and drug and alcohol 
addiction as well as crisis intervention in an 
inpatient psychiatric facility; used verbal de-
escalation protocols to manage conflicts between 
patients. 
 
Supervisors: Cathy Durst, M.S. L.P.C., Kina Howard, R.N., 
Cedar Springs Hospital  
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Fall 2009- 
Spring 2010 
Undergraduate Group Psychotherapy  
Group Counseling Facilitator 
Indiana Wesleyan University 
Marion, IN  
 
Duties: Provided evidence-based group psychotherapy to 
undergraduate students enrolled in a group 
counseling course; participated in weekly individual 
supervision.  
 
Supervisors: Keith Puffer, Ph.D., Doug Daugherty, Psy.D., 
Department of Psychology, Indiana Wesleyan 
University  
 
 
PEER SUPERVISION 
Fall 2014 Provided weekly clinical peer supervision to a graduate-level student 
during the student’s neuropsychology practicum placement. Attended 
a monthly course on providing clinical supervision facilitated by the 
Director of Clinical Training. 
 
Spring 2014 Provided weekly clinical peer supervision to a graduate-level student 
during the student’s health psychology practicum placement. 
Attended a monthly course on providing clinical supervision 
facilitated by the Assistant Director of Clinical Training. 
 
CLINICAL WORKSHOPS AND TRAINING EXPERIENCES  
January 
2016 
Interpersonal Process Group Therapy 
Diane Sobel, Ph.D., Training Director, University of Kentucky  
 
March 2015  Acceptance and Commitment Therapy Workshop  
Jennifer Lydon-Lam, Ph.D., Richard L. Roudebush VA Medical 
Center  
 
April 2014  Biofeedback Workshop  
Eric Scott, Ph.D., Assistant Professor, Indiana University  
 
April 2013  Self-Hypnosis for Chronic Pain Management Workshop  
Mark P. Jensen, Ph.D., Associate Professor, University of Washington 
  
Fall 2012-
Spring 2015 
Meta-Supervision  
Attended monthly supervision meetings facilitated by a licensed 
clinical psychologist. Received supervision on clinical work and 
reported intervention progress. Received feedback on a transcribed 
therapy session. Received didactics and supervision on clinical peer 
supervision.  
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Fall 2011-
Present  
Proseminar on Professional Issues in Clinical Psychology  
Weekly professional development course covering advanced clinical 
topics such as case conference/case conceptualization and clinical 
practice issues. Relevant topics include: supervision, consulting, 
diversity, ethics, professionalism, teaching, research methods, 
licensure, and grant writing. 
 
MEMBERSHIPS IN PROFESSIONAL ASSOCIATIONS 
Fall 2011 – 
Present 
Society of Behavioral Medicine, Student Member 
 
 
Fall 2011 – 
Present 
American Psychological Association, Division 38 (Health 
Psychology), Student Member 
 
Spring 2007 
– Present 
Psi Chi, National Honors Society in Psychology 
 
 
TEACHING EXPERIENCE 
Spring 2016 B305: Undergraduate Statistics 
Instructor  
Department of Psychology, IUPUI 
Indianapolis, IN  
 
Fall 2015 B305: Undergraduate Statistics 
Instructor  
Department of Psychology, IUPUI 
Indianapolis, IN  
 
Summer 
2015 
B110: Undergraduate Introduction to Psychology  
Instructor  
Department of Psychology, IUPUI 
Indianapolis, IN  
 
Fall 2009- 
Summer 
2010 
Advanced Topics in Learning, Research Methods 
Teaching Assistant  
Indiana Wesleyan University 
Marion, IN  
 
SERVICE ACTIVITIES 
Fall 2014 Interview Housing Coordinator 
Organized housing for applicants interviewing for the IUPUI Clinical 
Psychology Ph.D. program. 
 
Fall 2013 Psychology Graduate School Information Panelist  
Served on a panel about applying to graduate programs in psychology. 
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Fall 2009-
Spring 2010 
Elected President of Psi Chi, the National Honors Society in 
psychology, Indiana Wesleyan University 
 
Fall 2007- 
Spring 2010 
 
Habitat for Humanity Collegiate Challenge volunteer 
 
